| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 6.43e-06 | 188 | 175 | 10 | GO:0005201 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 1.37e-04 | 12 | 175 | 3 | GO:0030023 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 2.24e-04 | 14 | 175 | 3 | GO:0097493 | |
| GeneOntologyMolecularFunction | glycosylceramide flippase activity | 2.28e-04 | 3 | 175 | 2 | GO:0140351 | |
| GeneOntologyMolecularFunction | calcium ion binding | HSPG2 ASAH2 MATN2 CBL LRP1B ITPR1 MMRN1 THBS1 FBN1 FBN2 MEGF6 MEGF8 LRP1 LRP2 LTBP3 AGRN PROC | 3.26e-04 | 749 | 175 | 17 | GO:0005509 |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 3.41e-04 | 16 | 175 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | tRNA (cytidine-3-)-methyltransferase activity | 4.53e-04 | 4 | 175 | 2 | GO:0052735 | |
| GeneOntologyMolecularFunction | collagen V binding | 7.51e-04 | 5 | 175 | 2 | GO:0070052 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 7.84e-04 | 21 | 175 | 3 | GO:0030228 | |
| GeneOntologyBiologicalProcess | response to wounding | EPPK1 HTR2A INHBA MATN2 ENPP4 LYST ITGB4 F11 TGFB1 MMRN1 THBS1 LPA DGKK LRP1 ADAM17 C5 HPS5 TNR KLKB1 PROC | 9.51e-07 | 659 | 176 | 20 | GO:0009611 |
| GeneOntologyBiologicalProcess | regulation of response to wounding | 2.72e-06 | 217 | 176 | 11 | GO:1903034 | |
| GeneOntologyBiologicalProcess | positive regulation of fibrinolysis | 6.03e-06 | 5 | 176 | 3 | GO:0051919 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | GPR155 INHBA TGFB1 TRIM33 THBS1 FBN1 FBN2 MEGF8 GLG1 LRP1 LRP2 ADAM17 LTBP3 SMAD1 SMAD5 | 6.78e-06 | 445 | 176 | 15 | GO:0141091 |
| GeneOntologyBiologicalProcess | heart development | MKKS HSPG2 ADAMTS1 INHBA SYNE1 TAB2 PLXND1 NEDD4 TGFB1 SMYD4 THBS1 FBN1 MEGF8 ADAMTS6 LRP1 LRP2 AKAP13 SMAD1 SMAD5 MGRN1 | 7.69e-06 | 757 | 176 | 20 | GO:0007507 |
| GeneOntologyBiologicalProcess | negative regulation of response to wounding | 1.28e-05 | 126 | 176 | 8 | GO:1903035 | |
| GeneOntologyBiologicalProcess | blood coagulation | 1.51e-05 | 260 | 176 | 11 | GO:0007596 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | GPR155 INHBA TGFB1 TRIM33 THBS1 FBN1 FBN2 MEGF8 GLG1 LRP1 LRP2 ADAM17 LTBP3 SMAD1 SMAD5 | 1.74e-05 | 482 | 176 | 15 | GO:0007178 |
| GeneOntologyBiologicalProcess | regulation of fibrinolysis | 1.80e-05 | 19 | 176 | 4 | GO:0051917 | |
| GeneOntologyBiologicalProcess | coagulation | 1.87e-05 | 266 | 176 | 11 | GO:0050817 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic neurotransmitter receptor internalization | 1.95e-05 | 39 | 176 | 5 | GO:0099149 | |
| GeneOntologyBiologicalProcess | hemostasis | 2.01e-05 | 268 | 176 | 11 | GO:0007599 | |
| GeneOntologyBiologicalProcess | negative regulation of wound healing | 2.10e-05 | 98 | 176 | 7 | GO:0061045 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | TGFB1 TRIM33 THBS1 FBN1 FBN2 GLG1 LRP1 ADAM17 LTBP3 SMAD1 SMAD5 | 2.63e-05 | 276 | 176 | 11 | GO:0007179 |
| GeneOntologyBiologicalProcess | regulation of body fluid levels | HTR2A ENPP4 LYST F11 STAT5A MMRN1 THBS1 LPA DGKK AKAP11 HPS5 MUC2 KLKB1 PROC | 2.76e-05 | 442 | 176 | 14 | GO:0050878 |
| GeneOntologyBiologicalProcess | axon guidance | HSPG2 MATN2 CYFIP2 MEGF8 LRP1 LRP2 ADAM17 TNR AGRN EPHA10 LGI1 | 3.53e-05 | 285 | 176 | 11 | GO:0007411 |
| GeneOntologyBiologicalProcess | neuron projection guidance | HSPG2 MATN2 CYFIP2 MEGF8 LRP1 LRP2 ADAM17 TNR AGRN EPHA10 LGI1 | 3.64e-05 | 286 | 176 | 11 | GO:0097485 |
| GeneOntologyBiologicalProcess | postsynaptic neurotransmitter receptor internalization | 7.31e-05 | 51 | 176 | 5 | GO:0098884 | |
| GeneOntologyBiologicalProcess | postsynaptic endocytosis | 7.31e-05 | 51 | 176 | 5 | GO:0140239 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | GPR155 INHBA RAPGEF1 CBL GFRA2 CYFIP2 STAT5A NEDD4 TGFB1 TRIM33 ERFE THBS1 FBN1 FBN2 MEGF8 GLG1 LRP1 LRP2 ADAM17 LTBP3 AGRN EPHA10 SMAD1 SMAD5 | 7.37e-05 | 1186 | 176 | 24 | GO:0007167 |
| GeneOntologyBiologicalProcess | kidney development | DLG5 FRAS1 ADAMTS1 CENPF PLXND1 TGFB1 FBN1 ADAMTS6 LRP2 C5 SMAD1 SMAD5 | 8.81e-05 | 372 | 176 | 12 | GO:0001822 |
| GeneOntologyBiologicalProcess | regulation of wound healing | 9.20e-05 | 166 | 176 | 8 | GO:0061041 | |
| GeneOntologyBiologicalProcess | bone development | 9.38e-05 | 264 | 176 | 10 | GO:0060348 | |
| GeneOntologyBiologicalProcess | fibrinolysis | 1.03e-04 | 29 | 176 | 4 | GO:0042730 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular signal transduction | GPR155 DLG5 HTR2A RASGRF1 INHBA NEK10 KSR2 GBP1 RAPGEF1 TAB2 CBL MBIP TAB3 NEDD4 TGFB1 CD84 ERFE THBS1 CD27 LRP1 AKAP13 ADAM17 AGRN CDON RBX1 | 1.14e-04 | 1299 | 176 | 25 | GO:1902533 |
| GeneOntologyBiologicalProcess | renal system development | DLG5 FRAS1 ADAMTS1 CENPF PLXND1 TGFB1 FBN1 ADAMTS6 LRP2 C5 SMAD1 SMAD5 | 1.25e-04 | 386 | 176 | 12 | GO:0072001 |
| GeneOntologyBiologicalProcess | regulation of blood coagulation | 1.30e-04 | 91 | 176 | 6 | GO:0030193 | |
| GeneOntologyBiologicalProcess | sexual reproduction | MKKS DMXL2 ERCC4 ADAMTS1 INHBA SYNE1 TOPBP1 TUBGCP5 ITPR1 TGFB1 SPATA31D4 SPATA31D3 RMI1 NLRP14 BRCA2 ADGRG2 CCNB3 TRIM28 CATSPER4 MROH2B SCAPER SMAD1 PMFBP1 RBX1 SMAD5 | 1.34e-04 | 1312 | 176 | 25 | GO:0019953 |
| GeneOntologyBiologicalProcess | neurotransmitter receptor internalization | 1.36e-04 | 58 | 176 | 5 | GO:0099590 | |
| GeneOntologyBiologicalProcess | smoothened signaling pathway | 1.38e-04 | 176 | 176 | 8 | GO:0007224 | |
| GeneOntologyBiologicalProcess | regulation of hemostasis | 1.46e-04 | 93 | 176 | 6 | GO:1900046 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | TGFB1 TRIM33 THBS1 FBN1 FBN2 GLG1 LRP1 ADAM17 LTBP3 SMAD1 SMAD5 | 1.53e-04 | 336 | 176 | 11 | GO:0071560 |
| GeneOntologyBiologicalProcess | regulation of receptor internalization | 1.64e-04 | 95 | 176 | 6 | GO:0002090 | |
| GeneOntologyBiologicalProcess | regulation of coagulation | 1.74e-04 | 96 | 176 | 6 | GO:0050818 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | TGFB1 TRIM33 THBS1 FBN1 FBN2 GLG1 LRP1 ADAM17 LTBP3 SMAD1 SMAD5 | 1.83e-04 | 343 | 176 | 11 | GO:0071559 |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | GPR155 INHBA TGFB1 TRIM33 THBS1 FBN1 FBN2 GLG1 LRP1 LRP2 ADAM17 | 2.02e-04 | 347 | 176 | 11 | GO:0090092 |
| GeneOntologyBiologicalProcess | double-strand break repair via homologous recombination | 2.17e-04 | 188 | 176 | 8 | GO:0000724 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | HSPG2 ZNF135 CUX2 SYNE1 MATN2 VSIG1 PLXND1 ATP10A PREX2 CYFIP2 ITPR1 NEDD4 TGFB1 MEGF8 SLITRK5 LRP1 LRP2 ADAM17 TNR MUC3A AGRN EPHA10 LGI1 | 2.17e-04 | 1194 | 176 | 23 | GO:0000902 |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | GPR155 CYFIP2 NEDD4 TGFB1 TRIM33 THBS1 FBN1 FBN2 GLG1 LRP1 LRP2 ADAM17 | 2.28e-04 | 412 | 176 | 12 | GO:0090287 |
| GeneOntologyBiologicalProcess | circulatory system development | MKKS HSPG2 THSD7A ADAMTS1 INHBA SYNE1 RAPGEF1 TAB2 PLXND1 NEDD4 TGFB1 SMYD4 THBS1 FBN1 MEGF8 ADAMTS6 ABCC8 LPA SLITRK5 LRP1 LRP2 AKAP13 C5 SMAD1 SMAD5 MGRN1 | 2.33e-04 | 1442 | 176 | 26 | GO:0072359 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | HSPG2 CUX2 SYNE1 MATN2 PLXND1 PREX2 CYFIP2 NEDD4 MEGF8 SLITRK5 LRP1 LRP2 ADAM17 TNR AGRN EPHA10 LGI1 | 2.37e-04 | 748 | 176 | 17 | GO:0048667 |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta receptor signaling pathway | 2.50e-04 | 192 | 176 | 8 | GO:0017015 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | HSPG2 CUX2 SYNE1 MATN2 PLXND1 PREX2 CYFIP2 NEDD4 MEGF8 SLITRK5 LRP1 LRP2 ADAM17 TNR MUC3A AGRN EPHA10 LGI1 | 2.58e-04 | 826 | 176 | 18 | GO:0048858 |
| GeneOntologyBiologicalProcess | recombinational repair | 2.68e-04 | 194 | 176 | 8 | GO:0000725 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to transforming growth factor beta stimulus | 2.78e-04 | 195 | 176 | 8 | GO:1903844 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 3.09e-04 | 69 | 176 | 5 | GO:0030195 | |
| GeneOntologyBiologicalProcess | regeneration | 3.25e-04 | 252 | 176 | 9 | GO:0031099 | |
| GeneOntologyBiologicalProcess | wound healing | EPPK1 HTR2A ENPP4 LYST F11 TGFB1 MMRN1 THBS1 LPA DGKK HPS5 KLKB1 PROC | 3.28e-04 | 493 | 176 | 13 | GO:0042060 |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 3.30e-04 | 70 | 176 | 5 | GO:1900047 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | GPR155 RAPGEF1 CBL CYFIP2 NEDD4 TGFB1 TRIM33 THBS1 FBN1 FBN2 MEGF8 GLG1 LRP1 LRP2 ADAM17 LTBP3 SMAD1 SMAD5 | 3.63e-04 | 850 | 176 | 18 | GO:0071363 |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 3.77e-04 | 72 | 176 | 5 | GO:0050819 | |
| GeneOntologyBiologicalProcess | regulation of receptor-mediated endocytosis | 3.92e-04 | 156 | 176 | 7 | GO:0048259 | |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 4.30e-04 | 4 | 176 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | regulation of axon extension involved in regeneration | 4.30e-04 | 4 | 176 | 2 | GO:0048690 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | HSPG2 CUX2 SYNE1 MATN2 PLXND1 PREX2 CYFIP2 NEDD4 MEGF8 SLITRK5 LRP1 LRP2 ADAM17 TNR AGRN EPHA10 LGI1 | 5.26e-04 | 802 | 176 | 17 | GO:0048812 |
| GeneOntologyBiologicalProcess | response to growth factor | GPR155 RAPGEF1 CBL CYFIP2 NEDD4 TGFB1 TRIM33 THBS1 FBN1 FBN2 MEGF8 GLG1 LRP1 LRP2 ADAM17 LTBP3 SMAD1 SMAD5 | 5.69e-04 | 883 | 176 | 18 | GO:0070848 |
| GeneOntologyBiologicalProcess | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 5.83e-04 | 218 | 176 | 8 | GO:0090101 | |
| GeneOntologyBiologicalProcess | neuron projection development | HSPG2 DLG5 CUX2 RASGRF1 ADAMTS1 SYNE1 MATN2 RAPGEF1 PLXND1 PREX2 CYFIP2 ITPR1 NEDD4 MEGF8 UHMK1 SLITRK5 LRP1 LRP2 ADAM17 TNR AGRN EPHA10 LGI1 | 6.09e-04 | 1285 | 176 | 23 | GO:0031175 |
| GeneOntologyBiologicalProcess | aorta development | 6.13e-04 | 80 | 176 | 5 | GO:0035904 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | 6.58e-04 | 337 | 176 | 10 | GO:0006898 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | HSPG2 CUX2 SYNE1 MATN2 PLXND1 PREX2 CYFIP2 NEDD4 MEGF8 SLITRK5 LRP1 LRP2 ADAM17 TNR AGRN EPHA10 LGI1 | 6.64e-04 | 819 | 176 | 17 | GO:0120039 |
| GeneOntologyBiologicalProcess | bone morphogenesis | 6.89e-04 | 124 | 176 | 6 | GO:0060349 | |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 7.12e-04 | 5 | 176 | 2 | GO:1905167 | |
| GeneOntologyBiologicalProcess | chemoattraction of axon | 7.12e-04 | 5 | 176 | 2 | GO:0061642 | |
| GeneOntologyBiologicalProcess | axon extension involved in regeneration | 7.12e-04 | 5 | 176 | 2 | GO:0048677 | |
| GeneOntologyBiologicalProcess | regulation of sprouting of injured axon | 7.12e-04 | 5 | 176 | 2 | GO:0048686 | |
| GeneOntologyBiologicalProcess | coronary vasculature development | 7.25e-04 | 83 | 176 | 5 | GO:0060976 | |
| GeneOntologyBiologicalProcess | gamete generation | MKKS DMXL2 ADAMTS1 INHBA SYNE1 TGFB1 SPATA31D4 SPATA31D3 NLRP14 BRCA2 ADGRG2 TRIM28 CATSPER4 MROH2B SCAPER SMAD1 PMFBP1 RBX1 SMAD5 | 7.50e-04 | 982 | 176 | 19 | GO:0007276 |
| GeneOntologyBiologicalProcess | positive regulation of chemokine production | 7.66e-04 | 84 | 176 | 5 | GO:0032722 | |
| GeneOntologyBiologicalProcess | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 8.05e-04 | 49 | 176 | 4 | GO:0031146 | |
| GeneOntologyBiologicalProcess | developmental growth | MKKS EPPK1 CYFIP2 STAT5A TGFB1 RMI1 THBS1 MEGF8 BRCA2 TRIM28 CTR9 LPA SCAPER LRP1 AKAP13 TNR AGRN SMAD1 | 8.16e-04 | 911 | 176 | 18 | GO:0048589 |
| GeneOntologyBiologicalProcess | striatum development | 8.35e-04 | 22 | 176 | 3 | GO:0021756 | |
| GeneOntologyBiologicalProcess | regulation of response to external stimulus | RIN3 EPPK1 HTR2A GBP1 ENPP4 F11 STAT5A TGFB1 CD84 MMRN1 THBS1 NLRP9 NLRP14 MEGF8 LPA LRP1 ADAM17 C5 TNR KLKB1 AGRN HSPA4 PROC | 8.42e-04 | 1316 | 176 | 23 | GO:0032101 |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | MKKS DMXL2 ADAMTS1 INHBA SYNE1 CBL STAT5A TGFB1 SPATA31D4 SPATA31D3 NLRP14 BRCA2 ADGRG2 TRIM28 CATSPER4 LPA MROH2B SCAPER LRP2 PMFBP1 RBX1 SMAD5 | 8.58e-04 | 1235 | 176 | 22 | GO:0003006 |
| GeneOntologyBiologicalProcess | negative regulation of multicellular organismal process | HSPG2 DLG5 EPPK1 ADAMTS1 INHBA DTX1 GBP1 F11 TGFB1 CD84 RASSF5 ERFE THBS1 FBN1 BRCA2 ACOT11 ABCC8 LPA TTC21B ADAM17 LTBP3 TNR KLKB1 PROC RBX1 | 8.73e-04 | 1488 | 176 | 25 | GO:0051241 |
| GeneOntologyBiologicalProcess | positive regulation of blood vessel endothelial cell migration | 8.98e-04 | 87 | 176 | 5 | GO:0043536 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | DLG5 CUX2 PLXND1 TGFB1 MEGF8 SYNJ1 SLITRK5 LRP1 LRP2 AGRN CDON | 9.58e-04 | 418 | 176 | 11 | GO:0051962 |
| GeneOntologyBiologicalProcess | protein localization to organelle | RANBP2 HTR2A SYNE1 MIS18A TOPBP1 GBP1 CBL NEDD4 TGFB1 RASSF5 TIMM8B BRCA2 TRIM28 TTC21B LRP2 AKAP11 HSPA4 TP53BP1 TCTN2 LGI1 | 1.05e-03 | 1091 | 176 | 20 | GO:0033365 |
| GeneOntologyBiologicalProcess | osteoblast fate commitment | 1.06e-03 | 6 | 176 | 2 | GO:0002051 | |
| GeneOntologyBiologicalProcess | regulation of mast cell apoptotic process | 1.06e-03 | 6 | 176 | 2 | GO:0033025 | |
| GeneOntologyBiologicalProcess | mast cell apoptotic process | 1.06e-03 | 6 | 176 | 2 | GO:0033024 | |
| GeneOntologyBiologicalProcess | sprouting of injured axon | 1.06e-03 | 6 | 176 | 2 | GO:0048682 | |
| GeneOntologyBiologicalProcess | negative regulation of immune system process | DLG5 RIN3 INHBA DTX1 GBP1 STAT5A TGFB1 CD84 RASSF5 ERFE THBS1 FBN1 C5 BTRC | 1.07e-03 | 631 | 176 | 14 | GO:0002683 |
| GeneOntologyBiologicalProcess | regulation of cell cycle | ADAMTS1 CENPF INHBA NEK10 ASAH2 AHCTF1 MDM1 TOPBP1 FSD1 TRRAP MBIP STAT5A TGFB1 BRCA2 CCNB3 UHMK1 TAS1R2 SENP6 ADAM17 BTRC TP53BP1 KIF11 | 1.07e-03 | 1256 | 176 | 22 | GO:0051726 |
| GeneOntologyBiologicalProcess | protein monoubiquitination | 1.16e-03 | 54 | 176 | 4 | GO:0006513 | |
| GeneOntologyBiologicalProcess | cartilage development | 1.18e-03 | 243 | 176 | 8 | GO:0051216 | |
| GeneOntologyBiologicalProcess | axonogenesis | HSPG2 MATN2 PLXND1 CYFIP2 MEGF8 SLITRK5 LRP1 LRP2 ADAM17 TNR AGRN EPHA10 LGI1 | 1.18e-03 | 566 | 176 | 13 | GO:0007409 |
| GeneOntologyBiologicalProcess | regulation of striated muscle tissue development | 1.22e-03 | 25 | 176 | 3 | GO:0016202 | |
| GeneOntologyBiologicalProcess | cell activation | DLG5 HTR2A INHBA DTX1 CBL LYST STAT5A NEDD4 TGFB1 CD84 MMRN1 RASSF5 THBS1 KLRF1 CD6 CD27 ARMC5 DGKK LRP1 ADAM17 HSPA4 TP53BP1 RBX1 | 1.25e-03 | 1356 | 176 | 23 | GO:0001775 |
| GeneOntologyBiologicalProcess | positive regulation of MAPK cascade | HTR2A INHBA NEK10 KSR2 RAPGEF1 MBIP TGFB1 CD84 THBS1 CD27 LRP1 ADAM17 CDON | 1.28e-03 | 571 | 176 | 13 | GO:0043410 |
| GeneOntologyBiologicalProcess | DNA recombination | ERCC4 TOPBP1 ERVK-7 REV3L SFR1 TRRAP TGFB1 RMI1 BRCA2 TP53BP1 | 1.28e-03 | 368 | 176 | 10 | GO:0006310 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | HSPG2 LAMB4 FRAS1 ADAMTS1 MATN2 ITGB4 TGFB1 MMRN1 THBS1 FBN1 FBN2 MEGF6 LPA LTBP3 MUC2 TNR USH2A AGRN CDON | 1.20e-07 | 530 | 176 | 19 | GO:0062023 |
| GeneOntologyCellularComponent | extracellular matrix | HSPG2 LAMB4 FRAS1 ADAMTS1 MATN2 ITGB4 TGFB1 MMRN1 THBS1 FBN1 FBN2 MEGF6 ADAMTS6 GLG1 LPA LTBP3 MUC2 TNR USH2A AGRN CDON | 1.67e-07 | 656 | 176 | 21 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | HSPG2 LAMB4 FRAS1 ADAMTS1 MATN2 ITGB4 TGFB1 MMRN1 THBS1 FBN1 FBN2 MEGF6 ADAMTS6 GLG1 LPA LTBP3 MUC2 TNR USH2A AGRN CDON | 1.76e-07 | 658 | 176 | 21 | GO:0030312 |
| GeneOntologyCellularComponent | basement membrane | 9.35e-07 | 122 | 176 | 9 | GO:0005604 | |
| GeneOntologyCellularComponent | ubiquitin ligase complex | ZSWIM8 FBXL13 FBXL6 NEDD4 FBXO25 MEGF8 BRCA2 YPEL5 BTRC RBX1 MGRN1 | 2.04e-04 | 352 | 176 | 11 | GO:0000151 |
| GeneOntologyCellularComponent | BLOC-2 complex | 2.10e-04 | 3 | 176 | 2 | GO:0031084 | |
| GeneOntologyCellularComponent | SCF ubiquitin ligase complex | 3.11e-04 | 70 | 176 | 5 | GO:0019005 | |
| GeneOntologyCellularComponent | Golgi lumen | 3.23e-04 | 109 | 176 | 6 | GO:0005796 | |
| GeneOntologyCellularComponent | transferase complex | ZSWIM8 RANBP2 FBXL13 NEK10 REV3L TRRAP MBIP FBXL6 NEDD4 FBXO25 MEGF8 BRCA2 PIK3C2B CCNB3 CTR9 YPEL5 BTRC RBX1 MGRN1 | 5.05e-04 | 963 | 176 | 19 | GO:1990234 |
| GeneOntologyCellularComponent | intracellular protein-containing complex | ZSWIM8 FBXL13 CENPF REV3L TRRAP MBIP HPS3 FBXL6 ITPR1 NEDD4 FBXO25 MEGF8 BRCA2 CTR9 YPEL5 HPS5 BTRC RBX1 MGRN1 | 5.65e-04 | 972 | 176 | 19 | GO:0140535 |
| HumanPheno | Cranial nerve paralysis | HSPG2 DMXL2 ERCC4 OSTM1 SYNE1 PLXND1 REV3L LYST ITGB4 ITPR1 TGFB1 SLC6A8 BRCA2 AGRN | 3.43e-05 | 329 | 63 | 14 | HP:0006824 |
| HumanPheno | Abnormal cranial nerve morphology | HSPG2 DMXL2 ERCC4 OSTM1 SYNE1 PLXND1 REV3L LYST ITGB4 PLEKHM1 ITPR1 TGFB1 SLC6A8 BRCA2 AGRN | 3.54e-05 | 375 | 63 | 15 | HP:0001291 |
| HumanPheno | Abnormal cranial nerve physiology | HSPG2 DMXL2 ERCC4 OSTM1 SYNE1 PLXND1 REV3L LYST ITGB4 ITPR1 TGFB1 SLC6A8 BRCA2 AGRN | 3.80e-05 | 332 | 63 | 14 | HP:0031910 |
| HumanPheno | Finger syndactyly | MKKS FRAS1 ERCC4 PLXND1 REV3L TRRAP ITGB4 MEGF8 BRCA2 SCAPER BTRC | 5.91e-05 | 218 | 63 | 11 | HP:0006101 |
| HumanPheno | Aplasia of the pectoralis major muscle | 6.09e-05 | 7 | 63 | 3 | HP:0009751 | |
| MousePheno | abnormal craniofacial morphology | MKKS HSPG2 DLG5 FRAS1 OSTM1 INHBA CACHD1 PLXND1 REV3L CBL LYST ITGB4 NEDD4 TGFB1 FBN1 FBN2 MEGF8 ADAMTS6 FAM120C GLG1 TTC21B LRP1 LRP2 AKAP13 LTBP3 HPS5 SMAD1 CDON SMAD5 TCTN2 MGRN1 | 1.54e-05 | 1372 | 142 | 31 | MP:0000428 |
| MousePheno | craniofacial phenotype | MKKS HSPG2 DLG5 FRAS1 OSTM1 INHBA CACHD1 PLXND1 REV3L CBL LYST ITGB4 NEDD4 TGFB1 FBN1 FBN2 MEGF8 ADAMTS6 FAM120C GLG1 TTC21B LRP1 LRP2 AKAP13 LTBP3 HPS5 SMAD1 CDON SMAD5 TCTN2 MGRN1 | 1.54e-05 | 1372 | 142 | 31 | MP:0005382 |
| MousePheno | hemorrhage | HSPG2 DLG5 FRAS1 ADAMTS1 RAPGEF1 TAB2 PLXND1 NEDD4 TGFB1 THBS1 FBN1 LPA SLITRK5 LRP1 ADAM17 PROC CDON SMAD5 MGRN1 | 4.20e-05 | 664 | 142 | 19 | MP:0001914 |
| Domain | EGF-like_CS | HSPG2 LAMB4 MATN2 LRP1B ITGB4 MMRN1 THBS1 FBN1 FBN2 MEGF6 MEGF8 LRP1 LRP2 ADAM17 LTBP3 TNR MUC3A AGRN EPHA10 PROC | 3.92e-13 | 261 | 172 | 20 | IPR013032 |
| Domain | EGF_2 | HSPG2 LAMB4 MATN2 LRP1B ITGB4 MMRN1 THBS1 FBN1 FBN2 MEGF6 MEGF8 LRP1 LRP2 LTBP3 TNR MUC3A AGRN EPHA10 PROC | 5.09e-12 | 265 | 172 | 19 | PS01186 |
| Domain | EGF_CA | HSPG2 MATN2 LRP1B MMRN1 THBS1 FBN1 FBN2 MEGF6 MEGF8 LRP1 LRP2 LTBP3 AGRN PROC | 6.68e-12 | 122 | 172 | 14 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | HSPG2 MATN2 LRP1B MMRN1 THBS1 FBN1 FBN2 MEGF6 MEGF8 LRP1 LRP2 LTBP3 AGRN PROC | 8.37e-12 | 124 | 172 | 14 | IPR001881 |
| Domain | EGF_1 | HSPG2 LAMB4 LRP1B ITGB4 MMRN1 THBS1 FBN1 FBN2 MEGF6 MEGF8 LRP1 LRP2 LTBP3 TNR USH2A MUC3A AGRN PROC | 2.47e-11 | 255 | 172 | 18 | PS00022 |
| Domain | EGF | HSPG2 FRAS1 MATN2 LRP1B MMRN1 THBS1 FBN1 FBN2 MEGF6 MEGF8 LRP1 LRP2 LTBP3 TNR MUC3A AGRN PROC | 6.19e-11 | 235 | 172 | 17 | SM00181 |
| Domain | EGF-like_dom | HSPG2 FRAS1 MATN2 LRP1B MMRN1 THBS1 FBN1 FBN2 MEGF6 MEGF8 LRP1 LRP2 LTBP3 TNR MUC3A AGRN PROC | 1.53e-10 | 249 | 172 | 17 | IPR000742 |
| Domain | EGF_3 | HSPG2 MATN2 LRP1B MMRN1 THBS1 FBN1 FBN2 MEGF6 MEGF8 LRP1 LRP2 LTBP3 TNR MUC3A AGRN PROC | 5.68e-10 | 235 | 172 | 16 | PS50026 |
| Domain | cEGF | 2.82e-09 | 26 | 172 | 7 | PF12662 | |
| Domain | cEGF | 2.82e-09 | 26 | 172 | 7 | IPR026823 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | MATN2 LRP1B MMRN1 FBN1 FBN2 MEGF6 MEGF8 LRP1 LRP2 LTBP3 PROC | 3.82e-09 | 106 | 172 | 11 | IPR000152 |
| Domain | EGF_CA | 6.54e-09 | 86 | 172 | 10 | PF07645 | |
| Domain | ASX_HYDROXYL | 2.86e-08 | 100 | 172 | 10 | PS00010 | |
| Domain | Growth_fac_rcpt_ | HSPG2 FRAS1 MATN2 LRP1B FBN1 FBN2 MEGF6 MEGF8 LRP1 LRP2 LTBP3 | 2.15e-07 | 156 | 172 | 11 | IPR009030 |
| Domain | EGF_Ca-bd_CS | 2.76e-07 | 97 | 172 | 9 | IPR018097 | |
| Domain | EGF_CA | 3.29e-07 | 99 | 172 | 9 | PS01187 | |
| Domain | EGF_Lam | 7.27e-07 | 35 | 172 | 6 | SM00180 | |
| Domain | Laminin_EGF | 7.27e-07 | 35 | 172 | 6 | PF00053 | |
| Domain | Laminin_EGF | 1.21e-06 | 38 | 172 | 6 | IPR002049 | |
| Domain | EGF | 2.53e-06 | 126 | 172 | 9 | PF00008 | |
| Domain | EGF_LAM_2 | 7.39e-06 | 30 | 172 | 5 | PS50027 | |
| Domain | EGF_LAM_1 | 7.39e-06 | 30 | 172 | 5 | PS01248 | |
| Domain | TB | 2.61e-05 | 7 | 172 | 3 | PF00683 | |
| Domain | - | 4.15e-05 | 8 | 172 | 3 | 3.90.290.10 | |
| Domain | TB_dom | 6.19e-05 | 9 | 172 | 3 | IPR017878 | |
| Domain | TB | 6.19e-05 | 9 | 172 | 3 | PS51364 | |
| Domain | APPLE | 8.43e-05 | 2 | 172 | 2 | PS00495 | |
| Domain | Apple | 8.43e-05 | 2 | 172 | 2 | IPR000177 | |
| Domain | APPLE | 8.43e-05 | 2 | 172 | 2 | SM00223 | |
| Domain | DUF5050 | 8.43e-05 | 2 | 172 | 2 | IPR032485 | |
| Domain | DUF5050 | 8.43e-05 | 2 | 172 | 2 | PF16472 | |
| Domain | EGF_extracell | 2.27e-04 | 60 | 172 | 5 | IPR013111 | |
| Domain | EGF_2 | 2.27e-04 | 60 | 172 | 5 | PF07974 | |
| Domain | FBN | 2.51e-04 | 3 | 172 | 2 | IPR011398 | |
| Domain | Ras_G-nucl-exch_fac_CS | 2.59e-04 | 14 | 172 | 3 | IPR019804 | |
| Domain | SEA | 2.59e-04 | 14 | 172 | 3 | SM00200 | |
| Domain | Ldl_recept_b | 2.59e-04 | 14 | 172 | 3 | PF00058 | |
| Domain | LDLRB | 2.59e-04 | 14 | 172 | 3 | PS51120 | |
| Domain | ZF_DAG_PE_1 | 3.07e-04 | 64 | 172 | 5 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 3.07e-04 | 64 | 172 | 5 | PS50081 | |
| Domain | Bbox_C | 3.22e-04 | 15 | 172 | 3 | IPR003649 | |
| Domain | BBC | 3.22e-04 | 15 | 172 | 3 | SM00502 | |
| Domain | LY | 3.22e-04 | 15 | 172 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 3.22e-04 | 15 | 172 | 3 | IPR000033 | |
| Domain | C1 | 3.30e-04 | 65 | 172 | 5 | SM00109 | |
| Domain | PE/DAG-bd | 3.55e-04 | 66 | 172 | 5 | IPR002219 | |
| Domain | LDLR_class-A_CS | 4.90e-04 | 40 | 172 | 4 | IPR023415 | |
| Domain | MeTrfase | 5.00e-04 | 4 | 172 | 2 | IPR026113 | |
| Domain | Ldl_recept_a | 7.71e-04 | 45 | 172 | 4 | PF00057 | |
| Domain | RasGEFN | 7.80e-04 | 20 | 172 | 3 | SM00229 | |
| Domain | - | 8.38e-04 | 46 | 172 | 4 | 4.10.400.10 | |
| Domain | RasGEF_N | 9.03e-04 | 21 | 172 | 3 | PF00618 | |
| Domain | LDLRA_1 | 9.85e-04 | 48 | 172 | 4 | PS01209 | |
| Domain | zf-RanBP | 1.04e-03 | 22 | 172 | 3 | PF00641 | |
| Domain | Ras-like_Gua-exchang_fac_N | 1.04e-03 | 22 | 172 | 3 | IPR000651 | |
| Domain | RASGEF_NTER | 1.04e-03 | 22 | 172 | 3 | PS50212 | |
| Domain | LDrepeatLR_classA_rpt | 1.07e-03 | 49 | 172 | 4 | IPR002172 | |
| Domain | LDLa | 1.07e-03 | 49 | 172 | 4 | SM00192 | |
| Domain | LDLRA_2 | 1.07e-03 | 49 | 172 | 4 | PS50068 | |
| Domain | ZnF_RBZ | 1.19e-03 | 23 | 172 | 3 | SM00547 | |
| Domain | ZF_RANBP2_2 | 1.19e-03 | 23 | 172 | 3 | PS50199 | |
| Domain | SEA | 1.19e-03 | 23 | 172 | 3 | PS50024 | |
| Domain | SEA_dom | 1.19e-03 | 23 | 172 | 3 | IPR000082 | |
| Domain | Methyltransf_12 | 1.23e-03 | 6 | 172 | 2 | IPR013217 | |
| Domain | Methyltransf_12 | 1.23e-03 | 6 | 172 | 2 | PF08242 | |
| Domain | ZF_RANBP2_1 | 1.35e-03 | 24 | 172 | 3 | PS01358 | |
| Domain | Znf_RanBP2 | 1.52e-03 | 25 | 172 | 3 | IPR001876 | |
| Domain | LRR_6 | 1.64e-03 | 55 | 172 | 4 | PF13516 | |
| Domain | RASGEF | 1.71e-03 | 26 | 172 | 3 | PS00720 | |
| Domain | CUE | 1.72e-03 | 7 | 172 | 2 | SM00546 | |
| Domain | Pan_app | 1.72e-03 | 7 | 172 | 2 | IPR003609 | |
| Domain | PAN | 1.72e-03 | 7 | 172 | 2 | PS50948 | |
| Domain | PAN_1 | 1.72e-03 | 7 | 172 | 2 | PF00024 | |
| Domain | Laminin_G | 2.00e-03 | 58 | 172 | 4 | IPR001791 | |
| Domain | hEGF | 2.12e-03 | 28 | 172 | 3 | PF12661 | |
| Domain | DWB | 2.28e-03 | 8 | 172 | 2 | SM00524 | |
| Domain | Yippee/Mis18/Cereblon | 2.28e-03 | 8 | 172 | 2 | IPR004910 | |
| Domain | MH2 | 2.28e-03 | 8 | 172 | 2 | PS51076 | |
| Domain | MH1 | 2.28e-03 | 8 | 172 | 2 | PS51075 | |
| Domain | CUE | 2.28e-03 | 8 | 172 | 2 | PF02845 | |
| Domain | Yippee-Mis18 | 2.28e-03 | 8 | 172 | 2 | PF03226 | |
| Domain | - | 2.28e-03 | 8 | 172 | 2 | 3.90.520.10 | |
| Domain | MAD_homology_MH1 | 2.28e-03 | 8 | 172 | 2 | IPR013019 | |
| Domain | Dwarfin | 2.28e-03 | 8 | 172 | 2 | IPR013790 | |
| Domain | Calx_beta | 2.28e-03 | 8 | 172 | 2 | SM00237 | |
| Domain | MH2 | 2.28e-03 | 8 | 172 | 2 | PF03166 | |
| Domain | SMAD_dom_Dwarfin-type | 2.28e-03 | 8 | 172 | 2 | IPR001132 | |
| Domain | Znf_U1 | 2.35e-03 | 29 | 172 | 3 | IPR003604 | |
| Domain | ZnF_U1 | 2.35e-03 | 29 | 172 | 3 | SM00451 | |
| Domain | RASGEF_CAT | 2.35e-03 | 29 | 172 | 3 | PS50009 | |
| Domain | RasGEF | 2.60e-03 | 30 | 172 | 3 | PF00617 | |
| Domain | - | 2.60e-03 | 30 | 172 | 3 | 1.10.840.10 | |
| Domain | RASGEF_cat_dom | 2.60e-03 | 30 | 172 | 3 | IPR001895 | |
| Domain | RasGEF | 2.60e-03 | 30 | 172 | 3 | SM00147 | |
| Domain | Ras_GEF_dom | 2.60e-03 | 30 | 172 | 3 | IPR023578 | |
| Domain | DH_1 | 2.71e-03 | 63 | 172 | 4 | PS00741 | |
| Domain | TSP_1 | 2.71e-03 | 63 | 172 | 4 | PF00090 | |
| Domain | Calx_beta | 2.91e-03 | 9 | 172 | 2 | IPR003644 | |
| Domain | PSI_integrin | 2.91e-03 | 9 | 172 | 2 | PF17205 | |
| Domain | Integin_beta_N | 2.91e-03 | 9 | 172 | 2 | IPR033760 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 1.16e-06 | 59 | 131 | 7 | M39886 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | HSPG2 ADAMTS1 ITGB4 TGFB1 THBS1 FBN1 FBN2 ADAM17 LTBP3 TNR KLKB1 AGRN | 2.30e-05 | 300 | 131 | 12 | M610 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.85e-05 | 258 | 131 | 11 | MM14572 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 4.24e-05 | 8 | 131 | 3 | M47850 | |
| Pathway | PID_ALK1_PATHWAY | 9.09e-05 | 26 | 131 | 4 | M185 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 1.14e-04 | 118 | 131 | 7 | MM15588 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 1.28e-04 | 161 | 131 | 8 | M27871 | |
| Pathway | WP_TGFBETA_SIGNALING_PATHWAY | 1.29e-04 | 53 | 131 | 5 | MM15880 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.29e-04 | 84 | 131 | 6 | M7098 | |
| Pathway | KEGG_TGF_BETA_SIGNALING_PATHWAY | 1.47e-04 | 86 | 131 | 6 | M2642 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING | 1.54e-04 | 55 | 131 | 5 | M39351 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 2.09e-04 | 32 | 131 | 4 | MM14854 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 2.15e-04 | 59 | 131 | 5 | M27218 | |
| Pathway | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | 3.29e-04 | 15 | 131 | 3 | M552 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 3.71e-04 | 37 | 131 | 4 | M27134 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 3.74e-04 | 143 | 131 | 7 | M27275 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 4.12e-04 | 38 | 131 | 4 | MM14874 | |
| Pathway | PID_ERBB4_PATHWAY | 4.12e-04 | 38 | 131 | 4 | M13 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 4.19e-04 | 68 | 131 | 5 | M27303 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 4.55e-04 | 39 | 131 | 4 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 4.55e-04 | 39 | 131 | 4 | MM15165 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 4.55e-04 | 39 | 131 | 4 | MM14601 | |
| Pubmed | ZNF211 THSD7A CD84 THBS1 FBN1 FBN2 MTMR3 LRP1 LRP2 LTBP3 ZNF730 TP53BP1 | 1.91e-15 | 71 | 176 | 12 | 33541421 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | HSPG2 FRAS1 MATN2 CACHD1 PLXND1 MINPP1 LRP1B ITGB4 ITPR1 TGFB1 SLC6A8 THBS1 FBN1 FBN2 MEGF8 SNX32 TRIM28 GLG1 SCAPER RNFT1 SLITRK5 LRP1 TMPO ADAM17 LTBP3 AGRN CDON MGRN1 | 1.64e-11 | 1201 | 176 | 28 | 35696571 |
| Pubmed | HSPG2 PLXND1 MINPP1 ITGB4 F11 TGFB1 MMRN1 THBS1 MEGF8 LRP1 C5 KLKB1 PROC | 7.88e-10 | 257 | 176 | 13 | 16335952 | |
| Pubmed | ZSWIM8 DLGAP1 TNFRSF25 DMXL2 ADAMTS1 CNST SYNE1 CACHD1 REV3L TUBGCP5 LRP1B CBR3 CCDC85A TRIM33 THBS1 FBN1 SYNJ1 CTR9 MTMR3 LRP1 LRP2 SENP6 LTBP3 BTRC LGI1 | 8.72e-09 | 1285 | 176 | 25 | 35914814 | |
| Pubmed | Proteolysis of fibrillin-2 microfibrils is essential for normal skeletal development. | 2.55e-08 | 18 | 176 | 5 | 35503090 | |
| Pubmed | 2.55e-08 | 18 | 176 | 5 | 20530870 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HSPG2 FRAS1 RIN3 EPPK1 KSR2 RAPGEF1 PLXND1 REV3L TRRAP LYST ITGB4 PLEKHM1 SLC6A8 MEGF6 MEGF8 SYNJ1 PIK3C2B TRIM28 MTMR3 AKAP13 LTBP3 AGRN | 4.95e-08 | 1105 | 176 | 22 | 35748872 |
| Pubmed | Targeted disruption of Ras-Grf2 shows its dispensability for mouse growth and development. | 1.27e-07 | 3 | 176 | 3 | 11909944 | |
| Pubmed | 1.27e-07 | 3 | 176 | 3 | 25505291 | ||
| Pubmed | 1.27e-07 | 3 | 176 | 3 | 20855508 | ||
| Pubmed | 1.27e-07 | 3 | 176 | 3 | 29376829 | ||
| Pubmed | 1.27e-07 | 3 | 176 | 3 | 30125728 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | ZSWIM8 RANBP2 THSD7A ZNF385B TUBGCP5 PREX2 ITPR1 THBS1 SYNJ1 FAM120C LPA HSPA4 BTRC TP53BP1 | 1.60e-07 | 475 | 176 | 14 | 31040226 |
| Pubmed | 1.67e-07 | 118 | 176 | 8 | 21078624 | ||
| Pubmed | 2.00e-07 | 167 | 176 | 9 | 22159717 | ||
| Pubmed | 2.97e-07 | 175 | 176 | 9 | 28071719 | ||
| Pubmed | 5.08e-07 | 4 | 176 | 3 | 20729550 | ||
| Pubmed | Phospho-Smad1 modulation by nedd4 E3 ligase in BMP/TGF-β signaling. | 5.08e-07 | 4 | 176 | 3 | 21308777 | |
| Pubmed | Interaction of TGFβ and BMP signaling pathways during chondrogenesis. | 5.08e-07 | 4 | 176 | 3 | 21297990 | |
| Pubmed | 5.08e-07 | 4 | 176 | 3 | 7775583 | ||
| Pubmed | 5.08e-07 | 4 | 176 | 3 | 17359969 | ||
| Pubmed | 5.08e-07 | 4 | 176 | 3 | 28642261 | ||
| Pubmed | 5.08e-07 | 4 | 176 | 3 | 38246328 | ||
| Pubmed | 9.06e-07 | 64 | 176 | 6 | 22261194 | ||
| Pubmed | 1.16e-06 | 152 | 176 | 8 | 34299191 | ||
| Pubmed | Evaluation of candidate genes in a genome-wide association study of childhood asthma in Mexicans. | 1.26e-06 | 5 | 176 | 3 | 19910030 | |
| Pubmed | 1.26e-06 | 5 | 176 | 3 | 29253505 | ||
| Pubmed | Development, composition, and structural arrangements of the ciliary zonule of the mouse. | 1.26e-06 | 5 | 176 | 3 | 23493297 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | BDP1 ZSWIM8 DLG5 TOPBP1 TAB2 TRIM33 RMI1 BRCA2 SYNJ1 PIK3C2B CTR9 SENP6 GARRE1 TP53BP1 | 2.02e-06 | 588 | 176 | 14 | 38580884 |
| Pubmed | 2.41e-06 | 225 | 176 | 9 | 12168954 | ||
| Pubmed | 2.52e-06 | 6 | 176 | 3 | 23969417 | ||
| Pubmed | Genome-wide meta-analysis identifies new susceptibility loci for migraine. | 2.93e-06 | 78 | 176 | 6 | 23793025 | |
| Pubmed | 4.39e-06 | 7 | 176 | 3 | 12242711 | ||
| Pubmed | 4.39e-06 | 7 | 176 | 3 | 24657926 | ||
| Pubmed | 4.39e-06 | 7 | 176 | 3 | 15150273 | ||
| Pubmed | Purification and characterization of plasma protein C inhibitor. | 4.39e-06 | 7 | 176 | 3 | 2551064 | |
| Pubmed | 5.52e-06 | 50 | 176 | 5 | 23658023 | ||
| Pubmed | Putative functions of extracellular matrix glycoproteins in secondary palate morphogenesis. | 7.00e-06 | 8 | 176 | 3 | 23055981 | |
| Pubmed | Adamts17 is involved in skeletogenesis through modulation of BMP-Smad1/5/8 pathway. | 7.00e-06 | 8 | 176 | 3 | 31201465 | |
| Pubmed | 7.00e-06 | 8 | 176 | 3 | 23804438 | ||
| Pubmed | 7.00e-06 | 8 | 176 | 3 | 12684064 | ||
| Pubmed | DLGAP1 RANBP2 DMXL2 CENPF SYNE1 KSR2 CYFIP2 NEDD4 SYNJ1 FAM120C TRIM28 LRP1 TNR AGRN TP53BP1 KIF11 LGI1 | 8.85e-06 | 963 | 176 | 17 | 28671696 | |
| Pubmed | 1.02e-05 | 27 | 176 | 4 | 35894043 | ||
| Pubmed | Dlg5 maintains apical aPKC and regulates progenitor differentiation during lung morphogenesis. | 1.02e-05 | 27 | 176 | 4 | 23466739 | |
| Pubmed | GATA4 is essential for bone mineralization via ERα and TGFβ/BMP pathways. | 1.05e-05 | 9 | 176 | 3 | 24932701 | |
| Pubmed | 1.05e-05 | 9 | 176 | 3 | 12122015 | ||
| Pubmed | 1.05e-05 | 9 | 176 | 3 | 15993878 | ||
| Pubmed | 1.05e-05 | 9 | 176 | 3 | 19103752 | ||
| Pubmed | 1.05e-05 | 9 | 176 | 3 | 21454478 | ||
| Pubmed | 1.05e-05 | 9 | 176 | 3 | 30554948 | ||
| Pubmed | 1.05e-05 | 9 | 176 | 3 | 19018011 | ||
| Pubmed | 1.05e-05 | 9 | 176 | 3 | 25378163 | ||
| Pubmed | Dullard/Ctdnep1 regulates endochondral ossification via suppression of TGF-β signaling. | 1.05e-05 | 9 | 176 | 3 | 25155999 | |
| Pubmed | Genetic link between renal birth defects and congenital heart disease. | 1.18e-05 | 28 | 176 | 4 | 27002738 | |
| Pubmed | Global genetic analysis in mice unveils central role for cilia in congenital heart disease. | 1.24e-05 | 100 | 176 | 6 | 25807483 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 1.31e-05 | 101 | 176 | 6 | 23382219 | |
| Pubmed | 1.49e-05 | 10 | 176 | 3 | 23620745 | ||
| Pubmed | ZSWIM8 ADAMTS1 AHCTF1 REV3L TUBGCP5 TRRAP FBXL6 TRIM33 FBN2 CCNB3 FAM120C TRIM28 SCAPER LRP1 LRP2 ADAM17 GARRE1 TCTN2 | 1.61e-05 | 1116 | 176 | 18 | 31753913 | |
| Pubmed | HSPG2 CACHD1 TGFB1 FBN2 MEGF8 TRIM28 LRP1 TMPO ADAM17 LTBP3 KIF11 TCTN2 MGRN1 | 1.61e-05 | 613 | 176 | 13 | 22268729 | |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 1.71e-05 | 219 | 176 | 8 | 31353912 | |
| Pubmed | 1.79e-05 | 31 | 176 | 4 | 25762570 | ||
| Pubmed | 1.88e-05 | 222 | 176 | 8 | 37071664 | ||
| Pubmed | 2.04e-05 | 11 | 176 | 3 | 24434549 | ||
| Pubmed | 2.04e-05 | 11 | 176 | 3 | 24639464 | ||
| Pubmed | Loss of nidogen-1 and -2 results in syndactyly and changes in limb development. | 2.04e-05 | 11 | 176 | 3 | 17023412 | |
| Pubmed | Telencephalic embryonic subtractive sequences: a unique collection of neurodevelopmental genes. | 2.24e-05 | 165 | 176 | 7 | 16107646 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 20610799 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 19224917 | ||
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 2.55e-05 | 2 | 176 | 2 | 15963947 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 27893734 | ||
| Pubmed | New Evidence Supporting the Role of FBN1 in the Development of Adolescent Idiopathic Scoliosis. | 2.55e-05 | 2 | 176 | 2 | 30044367 | |
| Pubmed | Genetic analysis of the contribution of LTBP-3 to thoracic aneurysm in Marfan syndrome. | 2.55e-05 | 2 | 176 | 2 | 26494287 | |
| Pubmed | Agrin and perlecan mediate tumorigenic processes in oral squamous cell carcinoma. | 2.55e-05 | 2 | 176 | 2 | 25506919 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 15131124 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 28187111 | ||
| Pubmed | Microfibril structure masks fibrillin-2 in postnatal tissues. | 2.55e-05 | 2 | 176 | 2 | 20404337 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 31974739 | ||
| Pubmed | Fibrillln mutations in Marfan syndrome and related phenotypes. | 2.55e-05 | 2 | 176 | 2 | 8791520 | |
| Pubmed | Ras regulates SCF(β-TrCP) protein activity and specificity via its effector protein NORE1A. | 2.55e-05 | 2 | 176 | 2 | 25217643 | |
| Pubmed | ADAMTS1 mediates the release of antiangiogenic polypeptides from TSP1 and 2. | 2.55e-05 | 2 | 176 | 2 | 17082774 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 14991768 | ||
| Pubmed | Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. | 2.55e-05 | 2 | 176 | 2 | 7744963 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 17141611 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 26408953 | ||
| Pubmed | Arg-Gly-Asp-containing domains of fibrillins-1 and -2 distinctly regulate lung fibroblast migration. | 2.55e-05 | 2 | 176 | 2 | 18006876 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 19672301 | ||
| Pubmed | [Expression and significance of TGF-beta1 and HSP70 in human laryngeal squamous cell carcinoma]. | 2.55e-05 | 2 | 176 | 2 | 17802821 | |
| Pubmed | The relative priority of prekallikrein and factors XI/XIa assembly on cultured endothelial cells. | 2.55e-05 | 2 | 176 | 2 | 12944405 | |
| Pubmed | Exome sequencing identified new mutations in a Marfan syndrome family. | 2.55e-05 | 2 | 176 | 2 | 24484584 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 23119075 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 30306291 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 12393578 | ||
| Pubmed | Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. | 2.55e-05 | 2 | 176 | 2 | 12598898 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 28124063 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 18674744 | ||
| Pubmed | Microfibrils at basement membrane zones interact with perlecan via fibrillin-1. | 2.55e-05 | 2 | 176 | 2 | 15657057 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 23756845 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 14583433 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 34445520 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 34012913 | ||
| Interaction | FBXO2 interactions | HSPG2 DLGAP1 FRAS1 OSTM1 CACHD1 PLXND1 MINPP1 ENPP4 LRP1B TGFB1 FBN1 FBN2 MEGF8 GLG1 LRP2 ADAM17 AGRN RBX1 TCTN2 MGRN1 | 3.83e-10 | 411 | 172 | 20 | int:FBXO2 |
| Interaction | ZDHHC15 interactions | ZNF211 THSD7A CD84 THBS1 FBN1 FBN2 MTMR3 LRP1 LRP2 LTBP3 ZNF730 TP53BP1 | 7.76e-10 | 125 | 172 | 12 | int:ZDHHC15 |
| Interaction | ZFP41 interactions | 5.39e-07 | 57 | 172 | 7 | int:ZFP41 | |
| Interaction | CACNA1A interactions | 1.11e-06 | 123 | 172 | 9 | int:CACNA1A | |
| Interaction | NTN5 interactions | 1.59e-06 | 24 | 172 | 5 | int:NTN5 | |
| Interaction | IGFL3 interactions | 3.56e-06 | 75 | 172 | 7 | int:IGFL3 | |
| Interaction | PRG2 interactions | HSPG2 ZSWIM8 FRAS1 ADAMTS1 MINPP1 TGFB1 ERFE THBS1 FBN2 GLG1 YPEL5 LTBP3 | 6.44e-06 | 285 | 172 | 12 | int:PRG2 |
| Interaction | SORBS1 interactions | 1.07e-05 | 123 | 172 | 8 | int:SORBS1 | |
| Interaction | FBN2 interactions | 1.93e-05 | 65 | 172 | 6 | int:FBN2 | |
| Interaction | RAPGEF1 interactions | 1.94e-05 | 39 | 172 | 5 | int:RAPGEF1 | |
| Interaction | ZNF224 interactions | 2.23e-05 | 20 | 172 | 4 | int:ZNF224 | |
| Interaction | PLK1 interactions | ZSWIM8 RANBP2 ERCC4 MIS18A TOPBP1 CBL TRRAP NEDD4 TRIM33 FBN2 BRCA2 TRIM28 MTMR3 HSPA4 TP53BP1 | 3.33e-05 | 510 | 172 | 15 | int:PLK1 |
| Interaction | YWHAZ interactions | BDP1 DLGAP1 DLG5 DMXL2 RIN3 RASGRF1 RASGRF2 KSR2 TAB2 USP46 CBL LYST TAB3 CYFIP2 ITPR1 NEDD4 PIK3C2B MTMR3 AKAP13 AKAP11 HSPA4 GARRE1 BTRC TP53BP1 KIF11 RBX1 | 5.47e-05 | 1319 | 172 | 26 | int:YWHAZ |
| Interaction | SKI interactions | 7.10e-05 | 160 | 172 | 8 | int:SKI | |
| Interaction | DYRK1A interactions | BDP1 TNFRSF25 DLG5 ADAMTS1 CENPF CACHD1 LRP1B ITGB4 THBS1 FBN1 LRP2 AKAP11 LTBP3 GARRE1 BTRC | 8.13e-05 | 552 | 172 | 15 | int:DYRK1A |
| Interaction | UBE2E1 interactions | 8.44e-05 | 164 | 172 | 8 | int:UBE2E1 | |
| Interaction | SIRPD interactions | 9.47e-05 | 86 | 172 | 6 | int:SIRPD | |
| Interaction | SDF2L1 interactions | HSPG2 FRAS1 FBXL6 ERFE MEGF8 GLG1 ADAM17 AGRN EPHA10 TCTN2 MGRN1 | 1.05e-04 | 322 | 172 | 11 | int:SDF2L1 |
| Cytoband | 9q21.32 | 5.13e-05 | 19 | 176 | 3 | 9q21.32 | |
| GeneFamily | Low density lipoprotein receptors | 9.20e-05 | 13 | 127 | 3 | 634 | |
| GeneFamily | Biogenesis of lysosomal organelles complex 2 | 1.46e-04 | 3 | 127 | 2 | 1038 | |
| GeneFamily | Zinc fingers RANBP2-type |RNA binding motif containing | 4.10e-04 | 21 | 127 | 3 | 89 | |
| GeneFamily | Fibronectin type III domain containing | 9.37e-04 | 160 | 127 | 6 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|Proteoglycans | 1.00e-03 | 7 | 127 | 2 | 570 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.20e-03 | 66 | 127 | 4 | 722 | |
| GeneFamily | SMAD family | 1.33e-03 | 8 | 127 | 2 | 750 | |
| GeneFamily | Phosphoinositide phosphatases | 1.45e-03 | 32 | 127 | 3 | 1079 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | LAMB4 FRAS1 MATN2 MMRN1 THBS1 FBN1 FBN2 LTBP3 TNR USH2A AGRN LGI1 | 7.75e-09 | 196 | 173 | 12 | M3008 |
| Coexpression | NABA_CORE_MATRISOME | HSPG2 LAMB4 FRAS1 MATN2 MMRN1 THBS1 FBN1 FBN2 LTBP3 TNR USH2A AGRN LGI1 | 3.98e-08 | 275 | 173 | 13 | M5884 |
| Coexpression | NABA_MATRISOME | HSPG2 LAMB4 FRAS1 ADAMTS1 INHBA MATN2 PLXND1 TGFB1 MMRN1 THBS1 FBN1 FBN2 MEGF6 MEGF8 ADAMTS6 LPA ADAM17 LTBP3 MUC2 TNR USH2A MUC3A AGRN LGI1 | 7.75e-08 | 1026 | 173 | 24 | M5889 |
| Coexpression | GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_DN | ZNF135 DMXL2 STAT5A ITPR1 NEDD4 MMRN1 CD27 MTMR3 SENP6 KCNS3 SMAD1 | 9.94e-08 | 200 | 173 | 11 | M9411 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 6.06e-07 | 191 | 173 | 10 | MM17059 | |
| Coexpression | NABA_MATRISOME | HSPG2 FRAS1 ADAMTS1 INHBA MATN2 PLXND1 TGFB1 MMRN1 ERFE THBS1 FBN1 FBN2 MEGF6 MEGF8 ADAMTS6 LPA ADAM17 LTBP3 MUC2 TNR AGRN LGI1 | 9.06e-07 | 1008 | 173 | 22 | MM17056 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | RANBP2 DMXL2 CENPF AHCTF1 TOPBP1 TAB2 REV3L TRRAP ITPR1 NEDD4 TRIM33 BRCA2 MTMR3 AKAP13 AKAP11 ADAM17 GARRE1 BTRC TP53BP1 KIF11 | 1.05e-06 | 856 | 173 | 20 | M4500 |
| Coexpression | NABA_CORE_MATRISOME | 1.95e-06 | 270 | 173 | 11 | MM17057 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | GPR155 BDP1 TNFRSF25 RANBP2 OSTM1 SYNE1 RAPGEF1 TAB2 REV3L CBL LYST CYFIP2 STAT5A ITPR1 TGFB1 CD84 RASSF5 TRIM33 CD6 CD27 GLG1 UHMK1 YPEL5 SENP6 AKAP13 AKAP11 | 5.62e-06 | 1492 | 173 | 26 | M40023 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL | TNFRSF25 DLG5 DPP10 CENPF INHBA MATN2 LYST ITPR1 MMRN1 SLC6A8 ABCC8 ZFHX2 PROC | 5.95e-06 | 429 | 173 | 13 | M45694 |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP | HSPG2 LAMB4 DLG5 FRAS1 RASGRF1 CENPF USP46 PLXND1 ATP10A CCDC85A SLC6A8 ADAMTS6 PIK3C2B TRIM28 GLG1 ZNF730 TP53BP1 TCTN2 | 2.66e-05 | 891 | 173 | 18 | M45033 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | ZSWIM8 TNFRSF25 DLG5 DMXL2 GBP1 USP46 LYST ITGB4 F11 SLC6A8 MEGF6 MEGF8 RNFT1 LRP1 SENP6 ZFHX2 AKAP13 TCTN2 | 3.46e-05 | 909 | 173 | 18 | M41018 |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR | 4.44e-05 | 59 | 173 | 5 | M47989 | |
| Coexpression | GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN | 4.65e-05 | 194 | 173 | 8 | M7306 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_MAC_UP | 5.18e-05 | 197 | 173 | 8 | M5401 | |
| Coexpression | GSE28783_ANTI_MIR33_VS_CTRL_ATHEROSCLEROSIS_MACROPHAGE_DN | 5.37e-05 | 198 | 173 | 8 | M8355 | |
| Coexpression | GSE39556_CD8A_DC_VS_NK_CELL_UP | 5.76e-05 | 200 | 173 | 8 | M9406 | |
| Coexpression | GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_DN | 5.76e-05 | 200 | 173 | 8 | M7162 | |
| Coexpression | GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_UP | 5.76e-05 | 200 | 173 | 8 | M7168 | |
| Coexpression | GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN | 5.76e-05 | 200 | 173 | 8 | M6021 | |
| Coexpression | GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_DN | 5.76e-05 | 200 | 173 | 8 | M7992 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 5.76e-05 | 200 | 173 | 8 | M5930 | |
| Coexpression | GSE20715_0H_VS_24H_OZONE_LUNG_UP | 5.76e-05 | 200 | 173 | 8 | M4366 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_MEGAKARYOCYTES | 6.40e-05 | 203 | 173 | 8 | M40286 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN | 8.58e-05 | 157 | 173 | 7 | M7733 | |
| Coexpression | DESCARTES_FETAL_SPLEEN_MEGAKARYOCYTES | 1.12e-04 | 114 | 173 | 6 | M40293 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_GRIA2_POS_ARTERIAL_ENDO_CELL | 1.18e-04 | 115 | 173 | 6 | M45752 | |
| Coexpression | GSE7768_OVA_ALONE_VS_OVA_WITH_LPS_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP | 1.36e-04 | 169 | 173 | 7 | M6851 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.39e-04 | 40 | 173 | 4 | M5887 | |
| Coexpression | LE_SKI_TARGETS_UP | 1.80e-04 | 17 | 173 | 3 | M362 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 1.85e-04 | 43 | 173 | 4 | MM3857 | |
| Coexpression | CAIRO_LIVER_DEVELOPMENT_DN | 1.97e-04 | 239 | 173 | 8 | MM1274 | |
| Coexpression | BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP | ADAMTS1 INHBA MATN2 GBP1 ENPP4 ATP10A CYFIP2 STAT5A THBS1 ADAMTS6 | 2.19e-04 | 378 | 173 | 10 | M34022 |
| Coexpression | GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_UP | 2.53e-04 | 187 | 173 | 7 | M6807 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_VENOUS_ENDOTHELIAL_CELL | 2.53e-04 | 85 | 173 | 5 | M45761 | |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | DLG5 ERCC4 CENPF TOPBP1 ZNF385B ENPP4 SFR1 ERFE RMI1 FBXO25 FBN1 BRCA2 TMPO KCNS3 AKAP11 CDON | 2.93e-04 | 892 | 173 | 16 | M18120 |
| Coexpression | LEE_NAIVE_T_LYMPHOCYTE | 2.97e-04 | 20 | 173 | 3 | M12367 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGFPL | 3.04e-04 | 322 | 173 | 9 | M39060 | |
| Coexpression | KONDO_PROSTATE_CANCER_WITH_H3K27ME3 | 3.16e-04 | 194 | 173 | 7 | M7281 | |
| Coexpression | HALLMARK_COAGULATION | 3.17e-04 | 138 | 173 | 6 | M5946 | |
| Coexpression | PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP | 3.26e-04 | 195 | 173 | 7 | M13736 | |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | AHCTF1 GBP1 ITPR1 TRIM33 ACOT11 TRIM28 SCAPER SENP6 AKAP13 TP53BP1 | 3.37e-04 | 399 | 173 | 10 | M41172 |
| Coexpression | LU_EZH2_TARGETS_DN | TNFRSF25 ADAMTS1 CACHD1 TAB3 CYFIP2 RASSF5 TRIM33 THBS1 FBN2 CTR9 | 3.43e-04 | 400 | 173 | 10 | M2140 |
| Coexpression | KRAS.LUNG.BREAST_UP.V1_DN | 3.56e-04 | 141 | 173 | 6 | M2898 | |
| Coexpression | GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_UP | 3.57e-04 | 198 | 173 | 7 | M4639 | |
| Coexpression | GSE11057_CD4_CENT_MEM_VS_PBMC_UP | 3.57e-04 | 198 | 173 | 7 | M3116 | |
| Coexpression | GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP | 3.68e-04 | 199 | 173 | 7 | M7530 | |
| Coexpression | GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_CD8A_DC_DN | 3.80e-04 | 200 | 173 | 7 | M9408 | |
| Coexpression | GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_UP | 3.80e-04 | 200 | 173 | 7 | M9455 | |
| Coexpression | GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_DN | 3.80e-04 | 200 | 173 | 7 | M4632 | |
| Coexpression | GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_UP | 3.80e-04 | 200 | 173 | 7 | M8050 | |
| Coexpression | GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_DN | 3.80e-04 | 200 | 173 | 7 | M8389 | |
| Coexpression | GSE18893_TCONV_VS_TREG_24H_CULTURE_DN | 3.80e-04 | 200 | 173 | 7 | M7289 | |
| Coexpression | GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_DN | 3.80e-04 | 200 | 173 | 7 | M8618 | |
| Coexpression | GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_6H_UP | 3.80e-04 | 200 | 173 | 7 | M6067 | |
| Coexpression | GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP | 3.80e-04 | 200 | 173 | 7 | M6477 | |
| Coexpression | GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_DN | 3.80e-04 | 200 | 173 | 7 | M5303 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 3.84e-04 | 143 | 173 | 6 | M9149 | |
| Coexpression | BENPORATH_CYCLING_GENES | DMXL2 ADAMTS1 CENPF MATN2 MDM1 TOPBP1 TAB2 ITPR1 RMI1 CTR9 TMPO AKAP13 KIF11 | 3.89e-04 | 648 | 173 | 13 | M8156 |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | HSPG2 THSD7A RASGRF2 ADAMTS1 RAPGEF1 ITGB4 PREX2 FBN1 ADAMTS6 PIK3C2B | 2.50e-09 | 179 | 175 | 10 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | HSPG2 RIN3 RASGRF2 LRP1B LYST ITGB4 MMRN1 ADAMTS6 TSPAN13 TNR | 3.62e-09 | 186 | 175 | 10 | 92092f11ecce22c14f244e42c499af0822977e6f |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | HSPG2 THSD7A RASGRF2 CACHD1 ITGB4 PREX2 MMRN1 ADAMTS6 PIK3C2B ABCC8 | 4.02e-09 | 188 | 175 | 10 | d582b76fc2faac526c9bf97503041129e1a6a211 |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|kidney / Disease (COVID-19 only), tissue and cell type | HSPG2 RASGRF2 ADAMTS1 RAPGEF1 PLXND1 CCDC85A PREX2 FBN1 ADAMTS6 PIK3C2B | 4.45e-09 | 190 | 175 | 10 | 1519f34d31fe0817184c5865a0bc9f0cb479b1a4 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | HSPG2 THSD7A RASGRF2 PLXND1 ITGB4 CCDC85A PREX2 FBN1 ADAMTS6 PIK3C2B | 5.17e-09 | 193 | 175 | 10 | 2e72309607902dabe3218888b22a77fe941f3570 |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | HSPG2 RIN3 RASGRF2 PLXND1 CCDC85A PREX2 NEDD4 ADAMTS6 PIK3C2B GARRE1 | 5.99e-09 | 196 | 175 | 10 | 145fcf73deba9638b391a1af6c39fa205dc9829f |
| ToppCell | Control_saline-Endothelial-Endothelial-Vein|Control_saline / Treatment groups by lineage, cell group, cell type | HSPG2 ADAMTS1 LRP1B LYST ITGB4 PREX2 MMRN1 FBN1 ADAMTS6 TSPAN13 | 7.27e-09 | 200 | 175 | 10 | e5f876910bc8cb390d9b46a48d9b6d4d57235551 |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | HSPG2 THSD7A RASGRF2 ADAMTS1 ITGB4 PREX2 NEDD4 PIK3C2B GARRE1 | 5.29e-08 | 185 | 175 | 9 | a7ae76058b2082020cadec49d63b9f4e24d21734 |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 5.80e-08 | 187 | 175 | 9 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | THSD7A RASGRF2 ADAMTS1 RAPGEF1 ITGB4 CCDC85A PREX2 ADAMTS6 PIK3C2B | 5.80e-08 | 187 | 175 | 9 | 40ffc06a3e3251d9b12da390210d3e045af7537a |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | HSPG2 THSD7A ADAMTS1 ITGB4 PREX2 FBN1 ADAMTS6 PIK3C2B GARRE1 | 6.36e-08 | 189 | 175 | 9 | b028466fcd36fdeceec752e55a24286a1cd62ae4 |
| ToppCell | Endothelial-endothelial_cell_of_artery|World / Lineage, Cell type, age group and donor | HSPG2 THSD7A RASGRF2 ADAMTS1 ITGB4 PREX2 ADAMTS6 PIK3C2B GARRE1 | 6.36e-08 | 189 | 175 | 9 | fdd89c71113ac99b7c800c6def8888e512ff1128 |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery|Children_(3_yrs) / Lineage, Cell type, age group and donor | HSPG2 THSD7A RASGRF2 ADAMTS1 ITGB4 PREX2 NEDD4 PIK3C2B GARRE1 | 6.65e-08 | 190 | 175 | 9 | f6c38d197fd9d69a4f97cb2e72cd4747984c1a86 |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.65e-08 | 190 | 175 | 9 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | HSPG2 THSD7A RASGRF2 PLXND1 ITGB4 PREX2 FBN1 ADAMTS6 PIK3C2B | 6.65e-08 | 190 | 175 | 9 | aed65d584ca0c25f6a8313c66b421a6618af82ea |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | HSPG2 THSD7A RASGRF2 ADAMTS1 MATN2 ITGB4 PREX2 PIK3C2B GARRE1 | 6.96e-08 | 191 | 175 | 9 | 50601ef0a5a8f2c2120922989e08e85bf2d9b4ab |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | HSPG2 THSD7A RASGRF2 INHBA RAPGEF1 ATP10A NEDD4 MMRN1 GARRE1 | 7.61e-08 | 193 | 175 | 9 | 2531266bc57339d4e2b22a88817008e32b8c1598 |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | HSPG2 THSD7A RASGRF2 INHBA RAPGEF1 ATP10A NEDD4 MMRN1 GARRE1 | 7.61e-08 | 193 | 175 | 9 | 01c2df9206f1527c578e808978e58196c35e72f5 |
| ToppCell | PCW_07-8.5|World / Celltypes from embryonic and fetal-stage human lung | 7.95e-08 | 194 | 175 | 9 | 5759c83308df017f1faae248e9b85388e25254f0 | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | HSPG2 RASGRF2 ADAMTS1 INHBA PLXND1 ATP10A ITGB4 MMRN1 GARRE1 | 7.95e-08 | 194 | 175 | 9 | b6cc849fa08599bff9839ef382d190cc964e273e |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | HSPG2 RIN3 RASGRF2 RAPGEF1 PLXND1 CCDC85A PREX2 ADAMTS6 PIK3C2B | 8.31e-08 | 195 | 175 | 9 | 6bdef651cf73d7381e5012d0eb3c809138fb6b92 |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | HSPG2 RIN3 RASGRF2 PLXND1 CCDC85A PREX2 NEDD4 ADAMTS6 PIK3C2B | 8.68e-08 | 196 | 175 | 9 | b8f89a50114932c08fc5daac4b549adfe9df8e66 |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | HSPG2 RIN3 RASGRF2 PLXND1 CCDC85A PREX2 NEDD4 ADAMTS6 PIK3C2B | 8.68e-08 | 196 | 175 | 9 | d0ff1082898d2db47c88d2678466514e9e9193d3 |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | HSPG2 THSD7A RASGRF2 ADAMTS1 CCDC85A PREX2 MMRN1 ADAMTS6 GARRE1 | 9.47e-08 | 198 | 175 | 9 | f7aa809040fa9f5782b92eec1f289d690eb5c7bd |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Artery|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | HSPG2 THSD7A RASGRF2 ADAMTS1 ITGB4 PREX2 ADAMTS6 PIK3C2B GARRE1 | 1.03e-07 | 200 | 175 | 9 | 34b279804475ea58fbb052b96f44128c082627a9 |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Artery|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | HSPG2 THSD7A RASGRF2 ADAMTS1 ITGB4 PREX2 ADAMTS6 PIK3C2B GARRE1 | 1.03e-07 | 200 | 175 | 9 | 8552cc7a439449b30b59760c3e8667217b9852b5 |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Artery-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | HSPG2 THSD7A RASGRF2 ADAMTS1 ITGB4 PREX2 ADAMTS6 PIK3C2B GARRE1 | 1.03e-07 | 200 | 175 | 9 | 45c08f1befe78553bbadcc2fcffb6138306638f3 |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | THSD7A RASGRF2 ADAMTS1 RAPGEF1 CCDC85A PREX2 ADAMTS6 PIK3C2B | 5.66e-07 | 179 | 175 | 8 | 2a53d94f6c30bf887dfe88f1693ea057218c852d |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.53e-07 | 189 | 175 | 8 | 12b6f1c3bf526b90e112374bf937701f645c5780 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 8.53e-07 | 189 | 175 | 8 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.23e-07 | 191 | 175 | 8 | 04c7aa2e39fdd08ca24c10d43b29a5e41a73b9e0 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.23e-07 | 191 | 175 | 8 | db8dd6bbba803585bdd6a55d5c403d383f2e9acf | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 9.23e-07 | 191 | 175 | 8 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.60e-07 | 192 | 175 | 8 | 52acaecd3703166f5ce3b328aff7c82bd142fee4 | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 9.60e-07 | 192 | 175 | 8 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.98e-07 | 193 | 175 | 8 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-06 | 194 | 175 | 8 | a429d22c8c9d0fd3bfa9f877a6364cecad68db30 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-06 | 194 | 175 | 8 | b0c15e7e4bcf30856fb628dedd7ba82df33489f5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-06 | 195 | 175 | 8 | 77e47d2e8b3eb7f7c9620369ccaf87581f923bdb | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.08e-06 | 195 | 175 | 8 | 023e3c97dd3696d74f002ff8da0c04d876c82aef | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-06 | 196 | 175 | 8 | 22767bcf0095d9eb0cbed7cdc74e4d32d9357e1b | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-06 | 196 | 175 | 8 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-06 | 196 | 175 | 8 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-06 | 196 | 175 | 8 | adee900dcd16dbaba15c58bdcace09ba20214950 | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-06 | 198 | 175 | 8 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-06 | 198 | 175 | 8 | b027a141ab531d0f5d6a26811a53427e7b0771dd | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-06 | 198 | 175 | 8 | 953630dbe3154b1b102b87de0feca2cbf124eabe | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-06 | 198 | 175 | 8 | 8e45551224fbb30c0658ad47dd98335ecf165437 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.26e-06 | 199 | 175 | 8 | b15304d3d3f6c254969b54a61bee3d9f368840b2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.26e-06 | 199 | 175 | 8 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.26e-06 | 199 | 175 | 8 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.26e-06 | 199 | 175 | 8 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.26e-06 | 199 | 175 | 8 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.30e-06 | 200 | 175 | 8 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Artery|Control_saline / Treatment groups by lineage, cell group, cell type | 1.30e-06 | 200 | 175 | 8 | 65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Artery|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.30e-06 | 200 | 175 | 8 | ac9ead34afa14067171833f5c277eaf06db7b02e | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-Macrophage|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.30e-06 | 200 | 175 | 8 | 2a1ba87ca4adf351ef8fa2b3154b86a5407b8f2f | |
| ToppCell | distal-2-Endothelial-Vein|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.30e-06 | 200 | 175 | 8 | 2785225956d2422acab90e99b7debe3709cf3308 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Bronchial_vessel|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.30e-06 | 200 | 175 | 8 | 71979bbcc035d5b8882f1502b5a8ef248aaba45a | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.30e-06 | 200 | 175 | 8 | ac6b8bc9998d303f788511b8f111e682ea9f3df8 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Vein|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.30e-06 | 200 | 175 | 8 | 7eb366b2c5394af7c77650bde6261e7dac67154e | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-Macrophage-Macrophages-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.30e-06 | 200 | 175 | 8 | 98f6a86fbbe5305c71dae91e7278de9813827935 | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Macrophages|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.30e-06 | 200 | 175 | 8 | d7b89a721988660d8010c804916f5d0ef2520ee2 | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-Macrophage-Macrophages|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.30e-06 | 200 | 175 | 8 | 1ed1c673184f0c6aae04f90edbb1383b1c1f64d9 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Bronchial_vessel-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.30e-06 | 200 | 175 | 8 | c55efd997392e99068b673542f56f1a209c5a6c8 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Bronchial_vessel|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.30e-06 | 200 | 175 | 8 | a18817d36b2b30a32e1513d36174bf98dfea2a92 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T|COVID-19_Severe / Disease, condition lineage and cell class | 1.30e-06 | 200 | 175 | 8 | f72bc3f6606ae77fe1b0a972e35b3ce0727804d9 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.52e-06 | 161 | 175 | 7 | 5f6b2d7f80a8ee16651e304481d2da3fae313824 | |
| ToppCell | metastatic_Brain-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 4.66e-06 | 168 | 175 | 7 | 4bf3f85aac4b335efa93d22c9ce7b153cb5ce152 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.04e-06 | 170 | 175 | 7 | 6c65ddb496030bb479ef346cc37a9d4dfa6b824f | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.23e-06 | 171 | 175 | 7 | 1597459c971d6befa991d59dc66b41b6a522f797 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.87e-06 | 174 | 175 | 7 | ccc79febfcf588d8294ffc712338be96de8a5033 | |
| ToppCell | CF-Lymphoid-pDC|CF / Disease state, Lineage and Cell class | 6.32e-06 | 176 | 175 | 7 | dd1e529a9e413bcaab43584afbe059e1464ffb53 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.81e-06 | 178 | 175 | 7 | 5f779a66aa42d1d8e8af17b4a08d5dcc733efd4c | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 7.33e-06 | 180 | 175 | 7 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | Severe-Lymphoid-pDC-|Severe / Condition, Lineage, Cell class and cell subclass | 7.59e-06 | 181 | 175 | 7 | 277ce4c49121da0990a5933b19d2c6af9bbe253e | |
| ToppCell | Severe-Lymphoid-pDC|Severe / Condition, Lineage, Cell class and cell subclass | 7.59e-06 | 181 | 175 | 7 | 2caecb7c5dcdad46fd02b4ffb73cb613ce835187 | |
| ToppCell | cellseq2-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-NK|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.87e-06 | 182 | 175 | 7 | 8ccffcbae28c374fd4161fb0d4cf2c49fae557f6 | |
| ToppCell | Healthy-CD8+_T_naive|World / disease group, cell group and cell class | 7.87e-06 | 182 | 175 | 7 | b7d9f02c29c92c8803e11f967ad6eea032cb4224 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.45e-06 | 184 | 175 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.45e-06 | 184 | 175 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 8.45e-06 | 184 | 175 | 7 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | wk_20-22-Epithelial-PNS-intermediate_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.45e-06 | 184 | 175 | 7 | 4e3ba64692868563a579902aa9c6f88cab5bce26 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.45e-06 | 184 | 175 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 8.76e-06 | 185 | 175 | 7 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.07e-06 | 186 | 175 | 7 | ffbc78058be8f0dc2e0335cc4c3195a636d17721 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.07e-06 | 186 | 175 | 7 | 1e67bfb248366d7395efdd2d5e70a97bdb2e68af | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.07e-06 | 186 | 175 | 7 | ed924852cd7132c8f6703522037dc22bd2c83193 | |
| ToppCell | Control-Endothelial_cells-Arterial_endothelial_cells|Control / group, cell type (main and fine annotations) | 9.39e-06 | 187 | 175 | 7 | 81affaab3fe3e1daea45ada6445e906ddd33950e | |
| ToppCell | COVID-NK-|COVID / Condition, Cell_class and T cell subcluster | 9.73e-06 | 188 | 175 | 7 | fabdd68a9734d35e75e1f4a4bfd5c531cfc099f1 | |
| ToppCell | facs-Trachea-3m-Endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.73e-06 | 188 | 175 | 7 | dd817059e1b4225e84733559f7839cc973b7dfd6 | |
| ToppCell | facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.73e-06 | 188 | 175 | 7 | 6ab5ce8569f896a0fe7a76b8b4a83661e5499b8c | |
| ToppCell | COVID-NK|COVID / Condition, Cell_class and T cell subcluster | 9.73e-06 | 188 | 175 | 7 | 0beaa671611110a11e46156f54f5202cc24967a4 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.73e-06 | 188 | 175 | 7 | ec0e241de2c8310b4417b9d4e2420d7a1662f1c0 | |
| ToppCell | Endothelial-Endothelial-E|Endothelial / shred on cell class and cell subclass (v4) | 9.73e-06 | 188 | 175 | 7 | 2777eb7689b271c199021fe7d9db88ccebff14de | |
| ToppCell | facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.73e-06 | 188 | 175 | 7 | 20072a2a3f9ecbe727c850629f19420cf60e4bc5 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-05 | 189 | 175 | 7 | db09d591b885ce2bc9e353f08b6694e2192582e1 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-05 | 189 | 175 | 7 | c45734970036e6d28d5e3fe7c9458fae38a3f624 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 189 | 175 | 7 | 30dc1725d43a60017fb12d706f1f85a33de4947e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 1.01e-05 | 189 | 175 | 7 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| Drug | Cefixime [79350-37-1]; Up 200; 8.8uM; HL60; HT_HG-U133A | DMXL2 RIN3 ZNF696 PREX2 THBS1 SCAPER RNFT1 TSPAN13 LRP2 AKAP13 PMFBP1 | 3.62e-07 | 197 | 174 | 11 | 1310_UP |
| Drug | Diprophylline [479-18-5]; Up 200; 15.8uM; MCF7; HT_HG-U133A | RIN3 ZNF211 TRRAP ITGB4 PREX2 TRIM33 CD6 SYNJ1 LRP2 AKAP13 TCTN2 | 3.81e-07 | 198 | 174 | 11 | 1689_UP |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A | USP46 ENPP4 FBXL6 NEDD4 TRIM33 BRCA2 PIK3C2B SENP6 TMPO KIF11 | 2.13e-06 | 190 | 174 | 10 | 2619_DN |
| Drug | monatepil | 2.52e-06 | 29 | 174 | 5 | CID000060810 | |
| Drug | PHA-00846566E [724718-26-7]; Down 200; 10uM; MCF7; HT_HG-U133A | 3.38e-06 | 200 | 174 | 10 | 7081_DN | |
| Drug | tranexamic acid | 9.49e-06 | 64 | 174 | 6 | CID000005526 | |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 10uM; PC3; HT_HG-U133A | 1.69e-05 | 191 | 174 | 9 | 3823_DN | |
| Drug | TAAD | 1.78e-05 | 21 | 174 | 4 | CID000133445 | |
| Drug | Tolazamide [1156-19-0]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 1.84e-05 | 193 | 174 | 9 | 2842_UP | |
| Drug | Naltrexone hydrochloride dihydrate [16676-29-2]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.84e-05 | 193 | 174 | 9 | 2209_UP | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; PC3; HT_HG-U133A | 1.92e-05 | 194 | 174 | 9 | 4281_DN | |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; PC3; HT_HG-U133A | 2.00e-05 | 195 | 174 | 9 | 6643_DN | |
| Drug | Spironolactone [52-01-7]; Up 200; 9.6uM; PC3; HT_HG-U133A | 2.00e-05 | 195 | 174 | 9 | 2064_UP | |
| Drug | Zalcitabine [7481-89-2]; Up 200; 19uM; MCF7; HT_HG-U133A | 2.00e-05 | 195 | 174 | 9 | 4799_UP | |
| Drug | Indomethacin [53-86-1]; Down 200; 11.2uM; HL60; HT_HG-U133A | 2.08e-05 | 196 | 174 | 9 | 2377_DN | |
| Drug | Dehydroisoandosterone 3-acetate [853-23-6]; Down 200; 12.2uM; PC3; HT_HG-U133A | 2.08e-05 | 196 | 174 | 9 | 6673_DN | |
| Drug | Foliosidine [2520-38-9]; Down 200; 13uM; PC3; HT_HG-U133A | 2.16e-05 | 197 | 174 | 9 | 4295_DN | |
| Drug | Vidarabine [5536-17-4]; Up 200; 15uM; PC3; HT_HG-U133A | 2.16e-05 | 197 | 174 | 9 | 5850_UP | |
| Drug | Amodiaquin dihydrochloride dihydrate [6398-98-7]; Down 200; 8.6uM; PC3; HT_HG-U133A | 2.16e-05 | 197 | 174 | 9 | 5747_DN | |
| Drug | 2-Aminobenzenesulfonamide [3306-62-5]; Down 200; 23.2uM; HL60; HT_HG-U133A | 2.34e-05 | 199 | 174 | 9 | 3063_DN | |
| Drug | Dioxybenzone [131-53-3]; Up 200; 16.4uM; HL60; HT_HG-U133A | 2.34e-05 | 199 | 174 | 9 | 3101_UP | |
| Drug | Suloctidil [54063-56-8]; Down 200; 11.8uM; PC3; HT_HG-U133A | 2.34e-05 | 199 | 174 | 9 | 6675_DN | |
| Drug | arginyl-lysine | 2.62e-05 | 46 | 174 | 5 | CID000333446 | |
| Drug | C4 m | 3.20e-05 | 79 | 174 | 6 | CID009543487 | |
| Drug | 7-tricosene | 5.81e-05 | 2 | 174 | 2 | CID006365493 | |
| Drug | Prochlorperazine dimaleate [84-02-6]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 9.53e-05 | 186 | 174 | 8 | 5010_DN | |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 9.89e-05 | 187 | 174 | 8 | 4989_DN | |
| Drug | Naringenine [480-41-1]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 9.89e-05 | 187 | 174 | 8 | 3278_DN | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; PC3; HT_HG-U133A | 1.10e-04 | 190 | 174 | 8 | 4274_UP | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 1.19e-04 | 192 | 174 | 8 | 4743_DN | |
| Drug | Selegiline hydrochloride [14611-52-0]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 1.23e-04 | 193 | 174 | 8 | 4146_DN | |
| Drug | Moxalactam disodium salt [64953-12-4]; Down 200; 7uM; HL60; HT_HG-U133A | 1.23e-04 | 193 | 174 | 8 | 3028_DN | |
| Drug | Tiaprofenic acid [33005-95-7]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 1.28e-04 | 194 | 174 | 8 | 4171_DN | |
| Drug | ST021200; Down 200; 10uM; PC3; HT_HG-U133A | 1.32e-04 | 195 | 174 | 8 | 7493_DN | |
| Drug | Cinchonine [118-10-5]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 1.32e-04 | 195 | 174 | 8 | 4107_UP | |
| Drug | Trioxsalen [3902-71-4]; Down 200; 17.6uM; PC3; HT_HG-U133A | 1.32e-04 | 195 | 174 | 8 | 5736_DN | |
| Drug | Gibberellic acid [77-06-5]; Down 200; 11.6uM; PC3; HT_HG-U133A | 1.32e-04 | 195 | 174 | 8 | 4234_DN | |
| Drug | Azapropazone [13539-59-8]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.32e-04 | 195 | 174 | 8 | 6522_DN | |
| Drug | Gliclazide [21187-98-4]; Down 200; 12.4uM; PC3; HT_HG-U133A | 1.32e-04 | 195 | 174 | 8 | 5089_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; HL60; HT_HG-U133A | 1.32e-04 | 195 | 174 | 8 | 1162_UP | |
| Drug | Capsaicin [404-86-4]; Down 200; 13uM; HL60; HT_HG-U133A | 1.32e-04 | 195 | 174 | 8 | 3034_DN | |
| Drug | estradiol, USP; Up 200; 0.1uM; HL60; HT_HG-U133A | 1.32e-04 | 195 | 174 | 8 | 2668_UP | |
| Drug | Nifenazone [2139-47-1]; Up 200; 13uM; PC3; HT_HG-U133A | 1.37e-04 | 196 | 174 | 8 | 7314_UP | |
| Drug | Sotalol hydrochloride [959-24-0]; Up 200; 13uM; MCF7; HT_HG-U133A | 1.37e-04 | 196 | 174 | 8 | 7338_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; HL60; HT_HG-U133A | 1.37e-04 | 196 | 174 | 8 | 1181_UP | |
| Drug | Atractyloside potassium salt [102130-43-8]; Up 200; 5uM; MCF7; HT_HG-U133A | 1.37e-04 | 196 | 174 | 8 | 3435_UP | |
| Drug | Ritodrine hydrochloride [23239-51-2]; Down 200; 12.4uM; PC3; HT_HG-U133A | 1.37e-04 | 196 | 174 | 8 | 4619_DN | |
| Drug | Ethamsylate [2624-44-4]; Up 200; 15.2uM; HL60; HT_HG-U133A | 1.37e-04 | 196 | 174 | 8 | 2915_UP | |
| Drug | Isopropamide iodide [71-81-8]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.37e-04 | 196 | 174 | 8 | 6781_UP | |
| Drug | Nisoxetine hydrochloride [57754-86-6]; Down 200; 13uM; PC3; HT_HG-U133A | 1.37e-04 | 196 | 174 | 8 | 5091_DN | |
| Drug | Fusidic acid sodium salt [751-94-0]; Up 200; 7.4uM; PC3; HT_HG-U133A | 1.37e-04 | 196 | 174 | 8 | 6754_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; MCF7; HT_HG-U133A | 1.37e-04 | 196 | 174 | 8 | 6934_UP | |
| Drug | Glipizide [29094-61-9]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.37e-04 | 196 | 174 | 8 | 1508_UP | |
| Drug | (d,l)-Tetrahydroberberine [522-97-4]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.37e-04 | 196 | 174 | 8 | 2818_DN | |
| Drug | 0173570-0000 [211245-44-2]; Down 200; 1uM; PC3; HT_HG-U133A | 1.37e-04 | 196 | 174 | 8 | 7391_DN | |
| Drug | Suramin sodium salt; Down 200; 10uM; MCF7; HT_HG-U133A | 1.37e-04 | 196 | 174 | 8 | 7496_DN | |
| Drug | Stachydrine hydrochloride; Down 200; 22.2uM; PC3; HT_HG-U133A | 1.37e-04 | 196 | 174 | 8 | 4469_DN | |
| Drug | Acetopromazine maleate salt [3598-37-6]; Down 200; 9uM; PC3; HT_HG-U133A | 1.37e-04 | 196 | 174 | 8 | 4494_DN | |
| Drug | Liothyronine [6893-02-3]; Down 200; 6.2uM; PC3; HT_HG-U133A | 1.37e-04 | 196 | 174 | 8 | 6602_DN | |
| Drug | Cloxacillin sodium salt [642-78-4]; Down 200; 8.8uM; PC3; HT_HG-U133A | 1.42e-04 | 197 | 174 | 8 | 2126_DN | |
| Drug | Clofilium tosylate [92953-10-1]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 1.42e-04 | 197 | 174 | 8 | 6830_UP | |
| Drug | Althiazide [5588-16-9]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 1.42e-04 | 197 | 174 | 8 | 6829_UP | |
| Drug | estradiol, USP; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.42e-04 | 197 | 174 | 8 | 1208_DN | |
| Drug | aspirin, USP; Up 200; 100uM; MCF7; HT_HG-U133A | 1.42e-04 | 197 | 174 | 8 | 6924_UP | |
| Drug | Iodipamide [606-17-7]; Down 200; 3.6uM; HL60; HT_HG-U133A | 1.42e-04 | 197 | 174 | 8 | 3111_DN | |
| Drug | Sulfaguanidine [57-67-0]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 1.42e-04 | 197 | 174 | 8 | 1495_DN | |
| Drug | Fludrocortisone acetate [514-36-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 1.42e-04 | 197 | 174 | 8 | 2328_UP | |
| Drug | Procaine hydrochloride [51-05-8]; Up 200; 14.6uM; PC3; HT_HG-U133A | 1.42e-04 | 197 | 174 | 8 | 1796_UP | |
| Drug | Saquinavir mesylate [149845-06-7]; Down 200; 5.2uM; PC3; HT_HG-U133A | 1.42e-04 | 197 | 174 | 8 | 5770_DN | |
| Drug | C75; Up 200; 10uM; MCF7; HT_HG-U133A | 1.42e-04 | 197 | 174 | 8 | 6423_UP | |
| Drug | Clebopride maleate [84370-95-6]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 1.47e-04 | 198 | 174 | 8 | 5412_DN | |
| Drug | Tomatidine [77-59-8]; Up 200; 9.6uM; HL60; HG-U133A | 1.47e-04 | 198 | 174 | 8 | 1754_UP | |
| Drug | Phenindione [83-12-5]; Down 200; 18uM; MCF7; HT_HG-U133A | 1.47e-04 | 198 | 174 | 8 | 5991_DN | |
| Drug | Triamterene [396-01-0]; Up 200; 15.8uM; HL60; HT_HG-U133A | 1.47e-04 | 198 | 174 | 8 | 1861_UP | |
| Drug | Cyclacillin [3485-14-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.47e-04 | 198 | 174 | 8 | 4358_UP | |
| Drug | Isocarboxazid [59-63-2]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 1.47e-04 | 198 | 174 | 8 | 4706_UP | |
| Drug | Deoxycorticosterone [64-85-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.47e-04 | 198 | 174 | 8 | 6476_UP | |
| Drug | Tolnaftate [2398-96-1]; Down 200; 13uM; MCF7; HT_HG-U133A | 1.47e-04 | 198 | 174 | 8 | 4805_DN | |
| Drug | Benzthiazide [91-33-8]; Down 200; 9.2uM; HL60; HT_HG-U133A | 1.47e-04 | 198 | 174 | 8 | 2989_DN | |
| Drug | Doxazosin mesylate [77883-43-3]; Down 200; 7.4uM; HL60; HT_HG-U133A | 1.47e-04 | 198 | 174 | 8 | 3024_DN | |
| Drug | Tropicamide [1508-75-4]; Up 200; 14uM; PC3; HT_HG-U133A | 1.47e-04 | 198 | 174 | 8 | 4280_UP | |
| Drug | Dorzolamide hydrochloride [130693-82-2]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.47e-04 | 198 | 174 | 8 | 3565_DN | |
| Drug | Riluzole hydrochloride; Up 200; 14.8uM; MCF7; HT_HG-U133A | 1.47e-04 | 198 | 174 | 8 | 4689_UP | |
| Drug | Dantrolene sodium salt [14663-23-1]; Up 200; 11.8uM; HL60; HT_HG-U133A | 1.47e-04 | 198 | 174 | 8 | 2369_UP | |
| Drug | Nafronyl oxalate [3200-06-4]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.47e-04 | 198 | 174 | 8 | 2622_UP | |
| Drug | diazepine | 1.50e-04 | 14 | 174 | 3 | CID000166734 | |
| Drug | Pirlindole mesylate [60762-57-4]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 1.52e-04 | 199 | 174 | 8 | 5497_DN | |
| Drug | Tinidazole [19387-91-8]; Down 200; 16.2uM; PC3; HT_HG-U133A | 1.52e-04 | 199 | 174 | 8 | 3813_DN | |
| Drug | Etomidate [33125-97-2]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 1.52e-04 | 199 | 174 | 8 | 7460_UP | |
| Drug | Ranitidine hydrochloride [66357-59-3]; Up 200; 11.4uM; PC3; HT_HG-U133A | 1.52e-04 | 199 | 174 | 8 | 6324_UP | |
| Drug | Tetrahydroxy-1,4-quinone monohydrate [319-89-1]; Up 200; 21uM; MCF7; HT_HG-U133A | 1.52e-04 | 199 | 174 | 8 | 3338_UP | |
| Drug | Edrophonium chloride [116-38-1]; Down 200; 19.8uM; PC3; HT_HG-U133A | 1.52e-04 | 199 | 174 | 8 | 6655_DN | |
| Drug | Disopyramide [3737-09-5]; Down 200; 11.8uM; HL60; HT_HG-U133A | 1.52e-04 | 199 | 174 | 8 | 2408_DN | |
| Drug | (-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.52e-04 | 199 | 174 | 8 | 3531_DN | |
| Drug | Mafenide hydrochloride [138-37-4]; Up 200; 18uM; PC3; HT_HG-U133A | 1.52e-04 | 199 | 174 | 8 | 5079_UP | |
| Drug | Cloxacillin sodium salt [642-78-4]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 1.52e-04 | 199 | 174 | 8 | 2289_DN | |
| Drug | Finasteride [98319-26-7]; Down 200; 10.8uM; PC3; HT_HG-U133A | 1.52e-04 | 199 | 174 | 8 | 3744_DN | |
| Drug | Guanabenz acetate [23256-50-0]; Down 200; 13.8uM; HL60; HG-U133A | 1.52e-04 | 199 | 174 | 8 | 2045_DN | |
| Drug | thioridazine hydrochloride; Down 200; 10uM; PC3; HT_HG-U133A | 1.57e-04 | 200 | 174 | 8 | 5921_DN | |
| Drug | Promethazine hydrochloride [58-33-3]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 1.57e-04 | 200 | 174 | 8 | 6477_UP | |
| Disease | Geleophysic dysplasia | 1.77e-06 | 5 | 167 | 3 | C3489726 | |
| Disease | Acromicric Dysplasia | 1.77e-06 | 5 | 167 | 3 | C0265287 | |
| Disease | Mobius Syndrome | 3.18e-05 | 2 | 167 | 2 | C0221060 | |
| Disease | Mobius II syndrome | 3.18e-05 | 2 | 167 | 2 | C0853240 | |
| Disease | hair colour measurement | FRAS1 RIN3 CUX2 ADAMTS1 INHBA REV3L ATP10A LYST LRP1 AKAP13 HPS5 PROC RBX1 | 5.17e-05 | 615 | 167 | 13 | EFO_0007822 |
| Disease | severe acute respiratory syndrome, COVID-19 | DLGAP1 RIN3 THSD7A LRP1B LYST CCDC85A PREX2 RASSF5 MEGF6 LTBP3 TNR | 5.19e-05 | 447 | 167 | 11 | EFO_0000694, MONDO_0100096 |
| Disease | Polydactyly | 5.59e-05 | 117 | 167 | 6 | C0152427 | |
| Disease | platelet storage pool deficiency (implicated_via_orthology) | 7.71e-05 | 15 | 167 | 3 | DOID:2223 (implicated_via_orthology) | |
| Disease | Bipolar Disorder | CUX2 HTR2A THSD7A RASGRF1 SYNE1 USP46 ITPR1 NEDD4 TGFB1 BRCA2 HSPA4 | 9.24e-05 | 477 | 167 | 11 | C0005586 |
| Disease | progressive familial intrahepatic cholestasis (implicated_via_orthology) | 9.52e-05 | 3 | 167 | 2 | DOID:0070221 (implicated_via_orthology) | |
| Disease | connective tissue disease (implicated_via_orthology) | 9.52e-05 | 3 | 167 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | prostate cancer (biomarker_via_orthology) | 1.90e-04 | 4 | 167 | 2 | DOID:10283 (biomarker_via_orthology) | |
| Disease | scoliosis (is_implicated_in) | 1.90e-04 | 4 | 167 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | FEV/FEC ratio | HSPG2 FRAS1 ADAMTS1 KSR2 MBIP CYFIP2 ITPR1 RASSF5 TRIM33 FBN1 MEGF6 SCAPER MTMR3 LRP1 KCNS3 LTBP3 HSPA4 CDON | 2.19e-04 | 1228 | 167 | 18 | EFO_0004713 |
| Disease | vital capacity | HSPG2 RIN3 ADAMTS1 INHBA SYNE1 TMEM74 PLEKHM1 ITPR1 RMI1 THBS1 ADAMTS6 PIK3C2B MTMR3 LRP2 KCNS3 LTBP3 PROC PMFBP1 | 2.36e-04 | 1236 | 167 | 18 | EFO_0004312 |
| Disease | partial thromboplastin time | 3.30e-04 | 24 | 167 | 3 | EFO_0004310 | |
| Disease | Obsessive-Compulsive Disorder | 4.71e-04 | 6 | 167 | 2 | C0028768 | |
| Disease | L-arginine measurement | 4.71e-04 | 27 | 167 | 3 | EFO_0006524 | |
| Disease | cholangiocarcinoma (is_marker_for) | 4.83e-04 | 64 | 167 | 4 | DOID:4947 (is_marker_for) | |
| Disease | histidine measurement | 5.43e-04 | 66 | 167 | 4 | EFO_0009769 | |
| Disease | Child Development Disorders, Specific | 5.84e-04 | 29 | 167 | 3 | C0085997 | |
| Disease | Child Development Deviations | 5.84e-04 | 29 | 167 | 3 | C0085996 | |
| Disease | rheumatoid arthritis (is_marker_for) | 6.43e-04 | 69 | 167 | 4 | DOID:7148 (is_marker_for) | |
| Disease | Developmental Disabilities | 6.46e-04 | 30 | 167 | 3 | C0008073 | |
| Disease | Hermansky-Pudlak syndrome (is_implicated_in) | 6.56e-04 | 7 | 167 | 2 | DOID:3753 (is_implicated_in) | |
| Disease | non-substance related disinhibited behaviour | 6.56e-04 | 7 | 167 | 2 | EFO_0005432 | |
| Disease | white matter volume measurement | 7.83e-04 | 32 | 167 | 3 | EFO_0008320 | |
| Disease | factor XI measurement | 8.72e-04 | 8 | 167 | 2 | EFO_0004694 | |
| Disease | mesangial proliferative glomerulonephritis (biomarker_via_orthology) | 8.72e-04 | 8 | 167 | 2 | DOID:4783 (biomarker_via_orthology) | |
| Disease | liver cirrhosis (biomarker_via_orthology) | 9.37e-04 | 34 | 167 | 3 | DOID:5082 (biomarker_via_orthology) | |
| Disease | migraine disorder | 1.02e-03 | 357 | 167 | 8 | MONDO_0005277 | |
| Disease | multiple myeloma (is_marker_for) | 1.11e-03 | 36 | 167 | 3 | DOID:9538 (is_marker_for) | |
| Disease | Acute Confusional Migraine | 1.12e-03 | 9 | 167 | 2 | C0521664 | |
| Disease | Status Migrainosus | 1.12e-03 | 9 | 167 | 2 | C0338489 | |
| Disease | Abdominal Migraine | 1.12e-03 | 9 | 167 | 2 | C0270858 | |
| Disease | Sick Headaches | 1.12e-03 | 9 | 167 | 2 | C0700438 | |
| Disease | adult respiratory distress syndrome (implicated_via_orthology) | 1.12e-03 | 9 | 167 | 2 | DOID:11394 (implicated_via_orthology) | |
| Disease | Cervical Migraine Syndrome | 1.12e-03 | 9 | 167 | 2 | C0007852 | |
| Disease | Hemicrania migraine | 1.12e-03 | 9 | 167 | 2 | C0018984 | |
| Disease | longitudinal BMI measurement | 1.23e-03 | 82 | 167 | 4 | EFO_0005937 | |
| Disease | DNA methylation | ERCC4 DPP10 LRP1B CCDC85A GFRA2 ADAMTS6 LPA MROH2B TNR USH2A PMFBP1 | 1.34e-03 | 656 | 167 | 11 | GO_0006306 |
| Disease | Hermanski-Pudlak Syndrome | 1.39e-03 | 10 | 167 | 2 | C0079504 | |
| Disease | aortic aneurysm | 1.39e-03 | 10 | 167 | 2 | EFO_0001666 | |
| Disease | diabetes mellitus biomarker | 1.39e-03 | 10 | 167 | 2 | EFO_0006842 | |
| Disease | Hermansky-Pudlak syndrome | 1.39e-03 | 10 | 167 | 2 | cv:C0079504 | |
| Disease | systolic blood pressure, self reported educational attainment | 1.39e-03 | 10 | 167 | 2 | EFO_0004784, EFO_0006335 | |
| Disease | executive function measurement | 1.41e-03 | 376 | 167 | 8 | EFO_0009332 | |
| Disease | late-onset Alzheimers disease | 1.43e-03 | 292 | 167 | 7 | EFO_1001870 | |
| Disease | response to statin, myopathy | 1.69e-03 | 11 | 167 | 2 | EFO_0004145, GO_0036273 | |
| Disease | cortical thickness | HSPG2 RIN3 FBXL13 INHBA MDM1 ZNF385B PLXND1 PLEKHM1 GFRA2 THBS1 FBN1 FBN2 MTMR3 LRP1 KCNS3 | 1.71e-03 | 1113 | 167 | 15 | EFO_0004840 |
| Disease | Amelogenesis Imperfecta | 2.02e-03 | 12 | 167 | 2 | C0002452 | |
| Disease | stenosing tenosynovitis | 2.02e-03 | 12 | 167 | 2 | EFO_0010822 | |
| Disease | Thromboembolism | 2.02e-03 | 12 | 167 | 2 | C0040038 | |
| Disease | breast carcinoma | RIN3 CUX2 FBXL13 NEK10 TAB2 ITPR1 FBN1 FBN2 BRCA2 GLG1 LPA MTMR3 KCNS3 HSPA4 | 2.04e-03 | 1019 | 167 | 14 | EFO_0000305 |
| Disease | asthma (is_implicated_in) | 2.04e-03 | 157 | 167 | 5 | DOID:2841 (is_implicated_in) | |
| Disease | colorectal cancer (is_marker_for) | 2.04e-03 | 157 | 167 | 5 | DOID:9256 (is_marker_for) | |
| Disease | Colorectal Carcinoma | RASGRF2 SYNE1 PREX2 HPS3 TGFB1 FBN2 CCNB3 TRIM28 ABCC8 LRP1 LRP2 | 2.27e-03 | 702 | 167 | 11 | C0009402 |
| Disease | kynurenic acid measurement | 2.38e-03 | 13 | 167 | 2 | EFO_0010506 | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 2.38e-03 | 13 | 167 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | Migraine Disorders | 2.38e-03 | 13 | 167 | 2 | C0149931 | |
| Disease | systemic lupus erythematosus (is_marker_for) | 2.40e-03 | 47 | 167 | 3 | DOID:9074 (is_marker_for) | |
| Disease | cognitive inhibition measurement | 2.87e-03 | 50 | 167 | 3 | EFO_0007969 | |
| Disease | lysophosphatidylethanolamine 18:0 measurement | 3.19e-03 | 15 | 167 | 2 | EFO_0010367 | |
| Disease | thrombosis (is_implicated_in) | 3.19e-03 | 15 | 167 | 2 | DOID:0060903 (is_implicated_in) | |
| Disease | Early Pregnancy Loss | 3.47e-03 | 109 | 167 | 4 | C3830362 | |
| Disease | Spontaneous abortion | 3.47e-03 | 109 | 167 | 4 | C0000786 | |
| Disease | Miscarriage | 3.47e-03 | 109 | 167 | 4 | C4552766 | |
| Disease | Abortion, Tubal | 3.47e-03 | 109 | 167 | 4 | C0000822 | |
| Disease | Ciliopathies | 3.59e-03 | 110 | 167 | 4 | C4277690 | |
| Disease | Stevens-Johnson syndrome, toxic epidermal necrolysis, response to anticonvulsant | 3.63e-03 | 16 | 167 | 2 | EFO_0004276, EFO_0004775, GO_0036277 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 3.71e-03 | 111 | 167 | 4 | EFO_0004530, EFO_0008595 | |
| Disease | seasonal gut microbiome measurement | 3.83e-03 | 112 | 167 | 4 | EFO_0007753 | |
| Disease | Sjogren's syndrome (implicated_via_orthology) | 4.10e-03 | 17 | 167 | 2 | DOID:12894 (implicated_via_orthology) | |
| Disease | Astrocytosis | 4.10e-03 | 17 | 167 | 2 | C3887640 | |
| Disease | Gliosis | 4.10e-03 | 17 | 167 | 2 | C0017639 | |
| Disease | Uterine leiomyoma, estrogen-receptor positive breast cancer | 4.59e-03 | 18 | 167 | 2 | EFO_1000649, HP_0000131 | |
| Disease | Abnormality of chromosome segregation | 4.81e-03 | 60 | 167 | 3 | HP_0002916 | |
| Disease | protein-glutamine gamma-glutamyltransferase e measurement | 4.81e-03 | 60 | 167 | 3 | EFO_0020690 | |
| Disease | response to opioid | 5.04e-03 | 61 | 167 | 3 | EFO_0008541 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 5.04e-03 | 61 | 167 | 3 | DOID:3587 (is_marker_for) | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 5.04e-03 | 61 | 167 | 3 | EFO_0008317, EFO_0008596, EFO_0020946 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 5.11e-03 | 19 | 167 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | inflammatory bowel disease (is_implicated_in) | 5.11e-03 | 19 | 167 | 2 | DOID:0050589 (is_implicated_in) | |
| Disease | carotid artery disease (is_marker_for) | 5.11e-03 | 19 | 167 | 2 | DOID:3407 (is_marker_for) | |
| Disease | obsolete aging | 5.25e-03 | 279 | 167 | 6 | GO_0007568 | |
| Disease | cystic fibrosis (is_marker_for) | 5.27e-03 | 62 | 167 | 3 | DOID:1485 (is_marker_for) | |
| Disease | forced expiratory volume | RIN3 THSD7A SYNE1 PLEKHM1 CYFIP2 PIK3C2B KCNS3 HSPA4 PROC PMFBP1 CDON | 5.45e-03 | 789 | 167 | 11 | EFO_0004314 |
| Disease | phospholipids in chylomicrons and extremely large VLDL measurement | 5.51e-03 | 63 | 167 | 3 | EFO_0022292 | |
| Disease | puberty onset measurement | 5.64e-03 | 125 | 167 | 4 | EFO_0005677 | |
| Disease | glomerulonephritis (biomarker_via_orthology) | 5.66e-03 | 20 | 167 | 2 | DOID:2921 (biomarker_via_orthology) | |
| Disease | Familial aplasia of the vermis | 5.66e-03 | 20 | 167 | 2 | cv:C0431399 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SCLRQCALLLQSDQD | 936 | Q7Z4L5 | |
| CTQTERNLSPSNSCE | 1516 | A6H8Y1 | |
| LSNLSENTCDNFCLV | 366 | Q7RTX7 | |
| SCLAVQAAACRALQA | 191 | A6NCS6 | |
| LLVRNCTITANAECA | 91 | P26842 | |
| NSCARLCLNQETVCL | 81 | Q9Y297 | |
| TVDSENRTNLSCEGC | 46 | P28223 | |
| QRNICNLSSICNDSA | 106 | Q8IZP9 | |
| SACELREAACLQQTQ | 641 | O00468 | |
| LCADSACQQNTVTSS | 661 | Q12802 | |
| LHQCVNSRCSQRLES | 1016 | Q5VU97 | |
| ANCAIQGDLESRDCS | 196 | Q8WXI4 | |
| CDQAVLQCSEASSNK | 921 | Q9UKA4 | |
| VESLTACQDSQCLQS | 201 | Q96C12 | |
| ACQDSQCLQSVVRAL | 206 | Q96C12 | |
| SRSNNDVKCSTCANL | 251 | O14490 | |
| SCVECSNQQGRIAAS | 61 | Q8TDJ6 | |
| LCLASSTCNFVSNEV | 361 | Q8N531 | |
| QLASVNSSIRLACCS | 266 | O14529 | |
| STEGLLNRQCISCNF | 456 | Q8N608 | |
| NATSQEACAALLDQC | 916 | O60312 | |
| INTENQETCESILNC | 941 | O94823 | |
| DGTQCNADSLDICIN | 671 | Q9UKP5 | |
| CASQRKQSCQEESLA | 236 | Q8WWL7 | |
| SSLDVRIACEQCQES | 236 | P08476 | |
| DLCIECQANQASATS | 51 | P62877 | |
| SCLVRNEANATRCVA | 1551 | P49792 | |
| VRNEASATKCIACQN | 1676 | P49792 | |
| CTCRNLHQSNTSRAE | 1746 | P98160 | |
| ECRSLIQLDCSQQEG | 161 | Q8WWW0 | |
| FTRQDLCGSQTCDTL | 356 | Q9UHI8 | |
| LADQCLTTALNCDQA | 486 | Q86XR2 | |
| NSNLCSQSLAARVLC | 346 | P30203 | |
| LSQATVAESSCRNLC | 261 | Q5KSL6 | |
| QVEASDTCAQCLSRI | 531 | Q14667 | |
| NEATICSLLLCNRND | 366 | Q9NPJ1 | |
| TNGNCRTSCREEQFL | 786 | Q86XX4 | |
| DESNQTCTARTCQVD | 916 | Q9NZR2 | |
| RSARCNQNIDCADAS | 2606 | Q9NZR2 | |
| LAADNRTCLSNCTAS | 3306 | Q9NZR2 | |
| NSDQTTCRIQDLCAM | 271 | O00339 | |
| QLCLNTEDSFVCQCS | 456 | O00339 | |
| LNADEAVTRGCALQC | 366 | P34932 | |
| ASTESCNQQLDLALC | 556 | P42166 | |
| RDSNRDCTNELSNSC | 501 | P46934 | |
| ENFLVDICRACNNTS | 1461 | Q14643 | |
| SRCNSQSCILAQEEE | 631 | Q7Z3F1 | |
| QAALSNLTCCIDRSL | 976 | Q13201 | |
| QNQLAACTRALESSE | 81 | Q9BTV5 | |
| NLLEVVSQCCEASSS | 846 | P52732 | |
| ANDTNSCELSPCRIN | 2471 | Q07954 | |
| LQDDLTCRAVNSSCR | 2511 | Q07954 | |
| RCINTGESCDNANST | 361 | Q9NR71 | |
| NSDNSNECVVCLSDL | 271 | O60291 | |
| ANREECARLNASLSC | 136 | Q6VAB6 | |
| NLAARTCCLFQNSVI | 371 | Q9UPZ3 | |
| LETRCTLQQDCTNSS | 571 | Q9Y4D7 | |
| QENTFSLQAACCAAL | 381 | Q6ZWH5 | |
| CCAALTELVLNDTNA | 391 | Q6ZWH5 | |
| LTTCQQTCRSLSEAD | 671 | Q02817 | |
| ASQDVNSCQDSQTLC | 3116 | Q02505 | |
| ICIQSRCQRNASLEA | 286 | Q4G0M1 | |
| TQCSQDRLINLDSCI | 241 | Q9Y6X5 | |
| SRDHLNQILSDSNCC | 356 | Q8TC05 | |
| CCDFSSTAIELVQTN | 211 | Q6P1Q9 | |
| NKSLNECESLLRSCQ | 771 | Q8TDM6 | |
| SQRLTCEDCLANSSQ | 951 | Q7Z7M0 | |
| SCTSENDCRINQREV | 1971 | Q7Z7M0 | |
| CKQNQEASSDRCSAL | 396 | P32455 | |
| NLQCAESTTCQAGAR | 571 | Q96RT8 | |
| ESCSQKLERENNRCN | 26 | Q8TCJ0 | |
| NEDICNTTSLENCTA | 476 | Q9BQ31 | |
| DEQLCGTLNNTCSSS | 1056 | P98164 | |
| QNCTRRTCSENEFTC | 2986 | P98164 | |
| SRALENASTFCVCQD | 306 | Q5JZY3 | |
| CANCLTNNSEELSNS | 171 | Q86WC4 | |
| NISEALQQCCDLSQL | 631 | Q96F07 | |
| CNTQAELLAAGCQRE | 61 | P16144 | |
| SCQQCLLVNSTRAAS | 201 | Q86Y01 | |
| CCDFSSTAIELVQTN | 211 | Q96IZ6 | |
| RLQEALTFTCNCSST | 386 | O00750 | |
| CQREVSFLNCSLDNG | 131 | P04070 | |
| CRQQGFSLEQTSAAC | 131 | A1A4V9 | |
| DALGSCIIDCNENTR | 106 | P63130 | |
| RALNEACESVIQTAC | 501 | Q92896 | |
| RVDSTTLLGNACQDC | 316 | Q9NWS6 | |
| DLCASRSADQTVLCQ | 101 | Q9NZS2 | |
| ILRKCSRNETCSNNT | 666 | P51587 | |
| LSCQRQNAESARCSL | 371 | P49454 | |
| VRANELCAAESNCSS | 41 | O00451 | |
| DITGTSCVDLNECNQ | 2436 | P35555 | |
| SCIDNNECTSDINLC | 2521 | P35555 | |
| DTTCSSCQAFLANLD | 1651 | P01031 | |
| ASLQGCCSEAEAQQT | 311 | O15063 | |
| QRTCCQDIVNDVSSD | 1186 | Q4KMG0 | |
| CALSRDSNECNNGNR | 1056 | Q9NX05 | |
| ATEARQCSDLLSQAQ | 811 | Q6PD62 | |
| NSSVAKSAQECQERC | 126 | P03951 | |
| CNLTQCSDAEGTAVA | 556 | P08519 | |
| CSCQGQLRQAEAENA | 216 | A2IDD5 | |
| VSHCRNLQELNVSDC | 241 | Q8NEE6 | |
| AGSRCSIDSQASLCQ | 181 | Q96PX6 | |
| ACNICTVDSDQLAQL | 636 | Q99698 | |
| LDESNCRNGVCENTR | 1041 | Q9NS15 | |
| IDCNQENSCARTDAI | 186 | Q9NS73 | |
| VNISSLQCLRAFENC | 136 | O75828 | |
| SLRLCNTGDNSVCTT | 371 | P03952 | |
| AADLQDNACRSCSCN | 321 | A4D0S4 | |
| FETLERASSQCQCQS | 151 | Q3LI81 | |
| LDTSQSSRACDCDQQ | 711 | P22681 | |
| CLDDLSCNQNEVEAS | 171 | Q8WYP5 | |
| SRSCQDIDECSFQNI | 1486 | P35556 | |
| NGDNLCQRNADCINS | 1856 | P35556 | |
| LTCNNCSENCSDVLF | 996 | Q9BY12 | |
| QDSLNNNESCTLSCE | 66 | Q6PJW8 | |
| SESNLDQNCLSRCST | 1081 | Q13615 | |
| DQNCLSRCSTEIFSE | 1086 | Q13615 | |
| CANLSVSRLSCDNFT | 186 | Q8NGH5 | |
| SRADTQAQALCAQCA | 896 | Q8TB24 | |
| DSRTCLAINSCALGN | 196 | O75095 | |
| ENENLRAELQCCSTQ | 661 | Q8TBY8 | |
| RAELQCCSTQLESSL | 666 | Q8TBY8 | |
| QLSCSLNSDSCLLQE | 261 | Q9Y4G2 | |
| ASLSRALQTQCCISS | 61 | P82675 | |
| LSVNQSNESDCIFIC | 176 | C9JL84 | |
| VNLDGCLSTDSAVNC | 1886 | O75445 | |
| CLSTDSAVNCRGNDS | 1891 | O75445 | |
| LLDTCAVCQQSLQSR | 121 | Q9UPN9 | |
| CVSALCRQLEAASLQ | 446 | Q8IYR2 | |
| RCPNSSALQEVRSCN | 676 | Q9UPZ6 | |
| SCSDLESQLNQLGEC | 6761 | Q8NF91 | |
| NNNLDACCAVLSQES | 36 | Q9NYJ8 | |
| NNNLEACCRALSQES | 36 | Q8N5C8 | |
| TNCLDCLDRTNSVQA | 381 | O43426 | |
| ITSNNLQCFTVRCSA | 386 | Q969F9 | |
| ENDCNLQSCSLRSSE | 461 | Q9H9A7 | |
| SDISQCVDNIRCNGL | 581 | O14827 | |
| CGCLDEDTQRQLSQA | 421 | P58107 | |
| NNSDSISARQLCADI | 201 | Q9UIB8 | |
| CQDISQAVNRTDSCA | 276 | Q6ZUB0 | |
| RHEDCANASLANLTC | 186 | P48029 | |
| TTLACCQDSDFVNSQ | 621 | Q7Z745 | |
| NLNVCESQSLDSGSC | 121 | Q86XK3 | |
| TSDISQCVDNIRCNG | 576 | Q13972 | |
| ECLSDSSIFVQSRNC | 346 | Q99717 | |
| ECLSDSSIFVQSRNC | 346 | Q15797 | |
| ENTRNECSGEILNNC | 386 | P42229 | |
| AARNCSLSQECTLDQ | 1046 | Q09428 | |
| LNNDTCCNSDCTLKE | 496 | P78536 | |
| TNDNCVLQAARCDAG | 581 | Q86WS4 | |
| QEITQCLESLSQCEA | 521 | Q7RTR0 | |
| NANNFLNEDACRTAC | 131 | Q8IUA0 | |
| CQDISQAVNRTDSCA | 276 | P0C874 | |
| CNECEKSFRQNSTLI | 281 | Q96PE6 | |
| RQCSDVDDICSICQA | 366 | Q5M7Z0 | |
| CDSLNNRCEGSSVQT | 406 | P07996 | |
| SCANCDTILTNRSEL | 16 | P62699 | |
| ECNQCGRAFSQSSLL | 551 | P52742 | |
| CTAINRLGNSSCEID | 211 | Q86XK7 | |
| ASARNDIQRNLNCCG | 116 | O95857 | |
| CDQCAISFSSQDLLT | 1771 | Q9C0A1 | |
| LQSCQTSEECELARA | 466 | Q9UNW1 | |
| SQEDTNCILLRCVSC | 101 | Q9NYP9 | |
| TENCELLSCSGENRT | 741 | O60673 | |
| SLDRDSGQCSRNTSC | 366 | Q13905 | |
| TACSCNLQISDLGLN | 376 | O94991 | |
| AHCSCDSRDNTLQVD | 221 | P01137 | |
| SNLQRCDLASCQSTR | 361 | O94964 | |
| NANCCQESAATGQLD | 156 | Q92752 | |
| ECRECGQAFSQSSNL | 266 | Q9H7X3 | |
| NQNDLTFRVSCRCSG | 201 | Q9BTF0 | |
| SQNADSCEICCLVLR | 106 | Q13398 | |
| CQSSFDSVILNCRSI | 436 | Q9GZR1 | |
| CNSNRNSIASFTSIC | 1111 | Q70Z35 | |
| LSCICEARQENEARS | 1036 | Q12888 | |
| VISCNVCQLRFNSDS | 156 | Q569K4 | |
| RCQACDEQASQVALE | 91 | Q93038 | |
| QVALENCSAVADTRC | 101 | Q93038 | |
| QECDNCLNATLSFNT | 361 | Q8TE23 | |
| CEECGRAFNQSSTLT | 426 | Q6ZMV8 | |
| NRLDSRTENCLSSCV | 46 | Q9Y5J9 | |
| SLCSFISEAESLCQN | 26 | A7E2V4 | |
| LTNETRCLNCETVSS | 176 | P62068 | |
| CLRDFSNTETLCSEQ | 211 | P62068 | |
| QVLICASDDRTCSQL | 406 | Q92889 | |
| ADTAATRAALCCQKQ | 31 | Q96NL1 | |
| QQLCCQRFERLSDSA | 341 | Q86XE0 | |
| NISNINASCVSESIC | 316 | Q92547 | |
| NASCVSESICNSLNS | 321 | Q92547 | |
| CSECGRAFSQNANLT | 251 | Q15937 | |
| NTLVAAANSLDNLCR | 3836 | Q9Y4A5 | |
| CDQECSSNLTTLFRR | 186 | Q96GX1 | |
| NCLAQAGLQSDTECT | 206 | Q8TAS1 | |
| KAATDAQDANQCCTS | 141 | Q13263 | |
| CTCTKDNALCENARS | 46 | O95970 | |
| ESCNLTVFCCLNISN | 766 | Q86W24 |